Jean de la Rosette, MD Dr de la Rosette is Professor and Chairman of the Department of Urology, at AMC University Hospital in Amsterdam, the Netherlands. He completed his medical degree and urology residency at St Radboud University Hospital in Nijmegen, the Netherlands. He subsequently was appointed consultant urologist and Director Minimal Invasive Urology at the Department of Urology at the St Radboud University Hospital in Nijmegen. Dr de la Rosette is the chairman of the committee on Minimal Invasive Treatment of Benign Prostatic Hyperplasia (BPH) of the International Consultation on BPH. He is also chairman of the committee on Renal Stone Disease of the International Consultation on Stone Diseases. Both consultations are patronised by the World Health Organisation (WHO). He is chairman of the European Society of Uro-Technology (ESUT) and board member of the Society of Endourology. He is a member of the executive board of the Société International d’Urologie (SIU). Dr. de la Rosette was chairman of the European Association of Urology (EAU) working party on BPH guidelines. Dr de la Rosette is author of over 400 peer reviewed publications and has authored many book chapters. He is the editor of books in the field of laparoscopy, renal carcinoma, prostate diseases, urological imaging and voiding dysfunction. He is also on the editorial board of the Journal of Endourology, the Journal of Urology, BJU International, the Central European Journal of Urology and European Urology. Dr de la Rosette is a member of various urological societies: e.g. the International Continence Society (ICS), the American Urological Association (AUA), the European Association of Urology (EAU) and the Société International d’Urologie (SIU). He is strongly committed to research and has been appointed as chairman of the CROES (Clinical Research Office of the Endourology Society). Dr. de la Rosette is the scientific chairman of the World Congress on Endourology 2012. He furthermore organizes the Challenges in Endourology meeting and the annual symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer. CURRICULUM VITAE PERSONALIA: Name First name Born Name spouse Home address Work address Telephone private Mobile phone Telephone at work Fax at work E-mail de la Rosette Jean 25 November 1957 at Heerlen, the Netherlands Laguna, Pilar Casparuslaan 511 1382 KR Weesp The Netherlands Academic Medical Center, Department of Urology Meibergdreef 9 1105 AZ Amsterdam The Netherlands +31(0)294–772010 +31(0)6–535 38 846 +31(0)20–566 60 30 +31(0)20–566 95 85 [email protected] TRAINING AND CURRENT POSITION: 1977 Medical study University Nijmegen, the Netherlands 1985 MD and start residency 1992 Consultant urologist and Director Minimal Invasive Urology, Department of Urology, University Hospital Nijmegen, the Netherlands 1994 PhD thesis 2002 Professor and Chairman of the Department of Urology, Academic Medical Center and University of Amsterdam, the Netherlands MEMBERSHIP: International Continence Society (ICS) Nederlandse Vereniging voor Urologie (NVU) Deutsche Gesellschaft für Urologie (DGU) American Urological Association (AUA) European Association of Urology (EAU) Société International d‟Urologie (SIU) Society of Endourology OTHER ACTIVITIES: Chairman Clinical Research Office of the Endourological Society (CROES) Member WHO committee on minimal invasive treatment of BPH Boardmember and past chairman European Society of Uro-Technology (ESUT) Member and past chairman EAU working party on BPH guidelines Member executive board Société International d‟Urologie (SIU) Assistant Editor Journal of Endourology Member at large - Editorial Board European Urology Member Board of directors Society of Endourology Editorial Board Member European Urological Review Curriculum Vitae 2 J. de la Rosette INTERNATIONAL ACTIVITES President WCE 2005 meeting Scientific Chairman WCE 2012 meeting Co-director Meeting on Focal Therapies June 6-8th 2012 Co-director Challenges in Endourology June 27-29th 2012 ASSISTANT/ASSOCIATE EDITOR Journal of Endourology Journal of Urology BJU International Journal of Central Europe Turkish Journal of Urology European Urology Advances in Urology CO-PROMOTER PHD THESIS: 1. dr.ir. R. Giesen: Beyond ultrasonographic imaging of the prostate – computer analysis and cancer detection (may 16th 1995). 2. dr. P.F.W.M. Rosier: Bladder function in elderly male patients (February 27th 1996). 3. dr.ir. A. Huijnen: Automated interpretation of ultrasonographic prostate images (March 29th 1996). 4. dr. K. Ezz El Din: Benign Prostatic Hyperplasia – clinical assessment and evaluation (June 24th 1996). 5. dr.ir. R.G. Aarnink: Automated contour detection – design and clinical applications in urology (September 10th 1996). 6. dr. M.J.A.M de Wildt: Transuretheral Microwave Thermotherapy – an evolving technology in the treatment of benign prostatic enlargement (September 24th 1996). 7. dr. W.P.J. Witjes: Micturation variables in the assessment and treatment of patients with lower urinary tract symptoms (May 21th 1997). 8. dr. E. te Slaa: Laser prostatectomy in the treatment of benign prostatic obstruction (May 27th 1997). 9. dr. Y. Xue: Cell Biological Aspects of Prostate Development and Disease (May 18th 1998). 10. dr. F.C.H. d’Ancona: Selection Criteria for High Energy TransUrethral Microwave Thermotherapy of the Prostate (January 27th 1999). 11. dr. H.P. Beerlage: New aspects in diagnosis and minimal invasive treatment of prostate cancer (November 29th 1999). 12. dr. B.S.S. Wadie: Objective Evaluation of Prostatic symptoms, a Prospective study (January 2000). 13. dr. G. Sonke: Principles of Diagnostic Research Applied to Lower Urinary Tract Symptoms (June 21st 2000). Curriculum Vitae 3 J. de la Rosette 14. dr. B.B.M. Kortman: Critical Evaluation of Urodynamic Studies in the Assessment and Treatment of Men with Lower Urinary Tract Symptoms (June 8th 2001). 15. dr. D. Floratos: Efficiancy assessment of Minimally Invasive Therapies for the management of BPH (May 14th 2001). dr. J.P.M. Sedelaar: Contrast ultrasonography in the detection and follow up of prostate cancer (February 7th 2002). 16. 17. dr. E.A.E. Francisca: Evaluation of TransUrethral Microwave Thermotherapy for Benign Prostatic Enlargement (February 21st 2002). PROMOTER PHD THESIS: 1. dr. C.A. Mochtar: prognostic factors for clinical progression after treatment of BPH. (April 4th 2006). 2. dr. S. Gravas: TUMT treatment of BPH: from evidence based guidelines to clinical practice (April 20th 2007). 3. dr. S.I. Langbein: Urothelial Carcinoma of the Urinary Tract: molecular analyses for clinical applications (September 28th 2007). 4. dr. M.M. Barendrecht: Bladder outlet obstruction and hypertrophy: mechanisms and consequences (November 21st 2008). 5. dr. M.M. van Dijk: Balancing clinical outcomes and quality of life aspects in the treatment of LUTS/BPH (January 22nd 2010). 6. dr.I.Kümmerlin: Renal Tumours in the Netherlands: A Decade of Pathology and a Plea for Biopsy (November 11th 2010). 7. dr.G.P. Haber: Application of Emerging Technologies to Urologic Oncology (November 16th 2010) 8. dr. E.C.C. Cauberg: Advancements in diagnostic imaging for urothelial carcinoma (October 12th 2011) 9. dr. P. Beemster: Defining the position of cryoablation in the therapeutic armamentarium of small renal masses (January 11th 2012) 10. dr. O.K.. Zaki Mahmoud: Facing challenges in penile prosthesis implantation (February 2nd 2012) CO-EDITOR BOOKS: 1. J.J.M.C.H. de la Rosette, I. Gill. Laparsocopic Urologic Surgery in Malignancies. Heidelberg: Springer 2005. 2. J.J.M.C.H. de la Rosette, H. Van Poppel, C. Sternberg. Renal Cell Cancer: Diagnosis and Therapy. Springer-Verlag London Limited 2008. 3. J.J.M.C.H. de la Rosette, M. Harisinghani, M. Manyak, H. Wijkstra. Imaging in Oncological Urology. Springer-Verlag London Limited 2009. Curriculum Vitae 4 J. de la Rosette 4. G.H. Badlani, G.W. Davila, M.C. Michel, J.J.M.C.H. de la Rosette. Continence in males and females. Current concepts and treatment strategies. Springer-Verlag London Limited 2009. 5. A. Bachmann and J.J.M.C.H. de la Rosette. Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms in Men. Oxford University Press 2012 (in press). PUBLICATIONS (peer reviewed) 1990: 1. J.J.M.C.H. de la Rosette and F.M.J. Debruyne. Extragonadal germ cell tumor invading the prostate. Eur Urol. 1990; 18: 77-79. 2. A.J.M. Hendrikx, J.J.M.C.H. de la Rosette, C.A.M. van Helvoort-van Dommelen, M.A.A.M. van Dijk, H. Semmelink, N.V.M. Rijntjes and F.M.J. Debruyne. Histologic analysis of ultrasonic images of the prostate: an accurate technique. Ultrasound in Med & Biol 1990; 16(7): 667-674. 1991: 3. J.J.M.C.H. de la Rosette, J.D.M. de Vries, M.T.W.T. Lock, F.M.J. Debruyne. Urethra plasty using the pedicled island flap technique in complicated urethral strictures. J Urol.1991; 146:40-42. 4. J.J.M.C.H. de la Rosette and F.M.J. Debruyne. Non-bacterial prostatitis: a comprehensive review. Urol Int. 1991; 46:121-125. 1992: 5. J.J.M.C.H. de la Rosette, H.F.M. Karthaus, F.M.J. Debruyne. Ultrasonographic findings in patients with non-bacterial prostatitis. Urol Int. 1992; 48: 323-326. 6. J.J.M.C.H. de la Rosette, M.R. Hubregtse, H.F.M. Karthaus, F.M.J. Debruyne. Results of a questionnaire among dutch urologists and general practitioners concerning diagnostics and results of treatment of patients with prostatitis syndromes. Eur Urol. 1992; 22: 14-18. 7. J.J.M.C.H. de la Rosette, H.F.M. Karthaus, Ph.E.V.A. van Kerrebroeck, Th. de Boo, F.M.J. Debruyne. The use of alfuzosin, a new alpha receptor blocking agent, in patients with prostatodynia and voiding symptoms of an irritative nature. Urology 1992. 9: 215-219. 8. H.P. Beerlage, J.J.M.C.H. de la Rosette, A.J. Frima. Association between haematoma after inguinal hernia repair and site of heparin injection. Eur J Surg. 1992; 158 :287-288. 9. J.J.M.C.H. de la Rosette, H.F.M. Karthaus, Ph.E.V.A. van Kerrebroeck, Th. de Boo, F.M.J. Debruyne. Research in “prostatitis syndromes”: the use of alfuzosin (a new alpha-1-receptor blocking agent) in patients mainly presenting with micturition Curriculum Vitae 5 J. de la Rosette complaints of an irritative nature and confirmed urodynamic abnormalities. Eur Urol. 1992; 22(3): 222-227. 1993: 10. J.J.M.C.H. de la Rosette, M.R. Hubregtse, E.J.H. Meuleman, M.V.M. StolkEngelaar, F.M.J. Debruyne. Diagnostics and treatment of 409 patients with prostatitis syndromes. Survey of results. Urology 1993; 41: 301-307. 11. J.J.M.C.H. de la Rosette, M.C.M. Ruijgrok, J. Jeuken, H.F.M. Karthaus, F.M.J. Debruyne. Personality variables involved in chronic prostatitis. Urology1993; 42: 654-662. 12. J.J.M.C.H. de la Rosette, M.R. Hubregtse, J.M. Wiersma, F.M.J. Debruyne. The value of urine cytology in the screening of patients with prostatitis syndromes. Acta Cytologica. 1993; 37: 711-712. 13. J.J.M.C.H. de la Rosette, H.F.M. Karthaus, H.E. Schaafsma, R. van Dijk. Workup and management of incidentally found hypoechoic lesions of the testis. Urol Int 1993; 51: 23-27. 14. J.J.M.C.H. de la Rosette. Diagnostiek en behandeling van patiënten met prostatitis klachten: veranderde inzichten? Nederlands Tijdschrift voor Urologie 1993; 1: 7-10. 15. J.J.M.C.H. de la Rosette, F.M.J.A. Froeling, F.M.J. Debruyne. Clinical results with microwave thermotherapy of benign prostatic hyperplasia. Eur Urol 1993; 23: 68-71. 16. J.D.M. de Vries, J.J.M.C.H. de la Rosette, E.J.K.J.E.M van Grunsven. Urethraplasty, using the preputial island flap technique: revisted. Eur Urol 1993; 24: 77-80. 17. R.G. Aarnink, A.L. Huynen, R.J.B. Giesen, J.J.M.C.H. de la Rosette, F.M.J. Debruyne, H. Wijkstra. Automated volume measurement of the prostate with AUDEX. J Endourol.1993; 7 (suppl. 1): S191. 1994: 18. J.J.M.C.H. de la Rosette. Microwave treatment of BPH: still an option? Arch Esp de Urol. 1994; 47(9): 889-894. 19. J.J.M.C.H. de la Rosette, M.J.A.M. de Wildt, G. Alivizatos, F.M.J.A. Froeling, F.M.J. Debruyne. Transurethral microwave thermotherapy (TUMT) in benign prostatic hyperplasia: placebo versus TUMT. Urology 1994; 44: 58-63. 20. F.M.J.A. Froeling, J.J.M.C.H. de la Rosette, F.M.J. Debruyne. Minimaal invasieve urologie: nieuwe ontwikkelingen van behandelingen in de urologie. NTVG 1994; 138(35): 1756-1760. 21. M.J.A.M. de Wildt, J.J.M.C.H. de la Rosette, F.M.J.A. Froeling, F.A.G. Bloem. R. Laduc, F.M.J. Debruyne. Transurethrale microgolf thermotherapie (TUMT) bij de behandeling van benigne prostaat hyperplasie. NTVG 1994; 138(35): 1764-1770. Curriculum Vitae 6 J. de la Rosette 22. F.M.J.A. Froeling, M.J.G. Sorber, J.J.M.C.H. de la Rosette, J.D.M. de Vries. The non-palpable testis and the changing role of laparoscopy. Urology 1994; 43(2): 222227. 23. R.J.B. Giesen, A.L. Huynen, J.J.M.C.H. de la Rosette, H.E. Schaafsma, M.P. van Iersel, R.G. Aarnink, F.M.J. Debruyne, H. Wijkstra. The reliability of computer/ analysis of ultrasonographic prostate images: the influence of inconsistent histopathology. Ultrasound in Medicine & Biology 1994; 20:871-876. 24. A.L. Huynen, R.J.B. Giesen, J.J.M.C.H. de la Rosette, R.G. Aarnink, F.M.J. Debruyne, H. Wijkstra. Analysis of ultrasonographic prostate images for the detection of prostatic carcinoma: the Automated Urologic Diagnostic EXpert system. Ultrasound in Med & Biol 1994; 20: 1-10. 25. G.J. Jager, J.O. Barentsz, J.J.M.C.H. de la Rosette, G. Rosenbusch. Preliminary results of endorectal surface coil magnetic resonance imaging for local staging of prostatic cancer. Radiologe 1994; 34: 129-133. 26. R.G. Aarnink, R.J.B. Giesen, A.L. Huynen, J.J.M.C.H. de la Rosette, F.M.J. Debruyne, H. Wijkstra. A practical clinical method for contour determination in ultrasonographic prostate images. Ultrasound in Medicine and Biology 1994; 20: 705-717. 27. M.J.A.M. de Wildt, J.J.M.C.H. de la Rosette, F.M.J. Debruyne. Retreatment rate after surgical and non-surgical treatments. Prog Clin Biol Res 1994; 386: 597-613. 28. J.J.M.C.H. de la Rosette, F.M.J.A. Froeling, G. Alivizatos, F.M.J. Debruyne. Laser ablation of the prostate: experience with an ultrasound guided technique and a procedure under direct vision. Eur Urol 1994; 25(1), 19-24. 29. J.J.M.C.H de la Rosette, A. Tubaro, K. Hofner, S.S. Carter. Transurethral microwave thermotherapy: past, present and future. World J Urol 1994; 12(6): 352356. 30. R.J.B. Giesen, A.L. Huynen, J.J.M.C.H de la Rosette, H.E. Schaafsma, M.P van Iersel, R.G. Aarnink, F.M.J. Debruyne, H. Wijkstra.The reliability of computer analysis of ultrasonographic prostate images: the influence of inconsistent histopathology. Ultrasound Med Biol 1994; 20(9): 871-876. 1995: 31. J.J.M.C.H. de la Rosette, R.J.B. Giesen, A.L. Huynen, R.G. Aarnink, M.P. van Iersel, F.M.J. Debruyne, H. Wijkstra. Automated analysis and interpretation of transrectal ultrasonography images in patients with prostatitis. Eur Urol 1995; 27: 4753. 32. J.J.M.C.H. de la Rosette, M.J.A.M. de Wildt, F.M.J. Debruyne, P.L. Kersten, H. Wijkstra. Reliability of uroflowmetry investigations: results of a portable homeflowmetry study. Neurourology and urodynamics 1995; 14: 534-536. Curriculum Vitae 7 J. de la Rosette 33. J.J.M.C.H. de la Rosette, R.J.B. Giesen, A.L. Huynen, R.G. Aarnink, F.M.J. Debruyne, H. Wijkstra. Computerized analysis of transrectal ultrasonography images in the detection of prostate carcinoma. Br J Urol 1995; 75: 485-491. 34. J.J.M.C.H. de la Rosette, E. Te Slaa, M.J.A.M. de Wildt, F.M.J. Debruyne. Experience with the Ultraline and Urolase laser fibers: is there any difference? World J Urol 1995; 13: 98-103. 35. J.J.M.C.H. de la Rosette, A. Tubaro, A. Trucchi, S.St.C. Carter, K Hofner. Changes in pressure-flow parameters in patients treated by TUMT (version 2.0). J Urol 1995; 153: 1526-1536. 36. M.J.A.M. de Wildt, J.J.M.C.H. de la Rosette. Transurethral microwave thermotherapy: an evolving technology in the treatment of benign prostatic enlargement. Br J Urol 1995; 76: 531-538. 37. P.F.W.M. Rosier, J.J.M.C.H. de la Rosette, E.L. Koldewijn, F.M.J. Debruyne, H. Wijkstra. Variability of pressure flow analysis parameters in repeated cystometry in patients with benign prostatic hyperplasia. J Urol 1995; 153: 1520-1525. 38. P.F.W.M. Rosier, J.J.M.C.H. de la Rosette. Is there a correlation between prostate size and bladder-outlet obstruction. World J Urol 1995; 13: 9-13. 39. P.F.W.M. Rosier, J.J.M.C.H. de la Rosette, E.L. Koldewijn, F.M.J. Debruyne, H. Wijkstra. Variability of pressure flow analysis in repeated cystometry in patients with benign prostatic hyperplasia. J Urol 1995; 153:1520-1525. 40. P.F.W.M. Rosier, M.J.A.M. de Wildt, J.J.M.C.H. de la Rosette, F.M.J. Debruyne, H. Wijkstra. Analysis of Maximum Detrusor Contraction Power in Relation to bladder emptying in patients with lower urinary tract symptoms and benign prostatic enlargement. J Urol 1995; 154: 2137-2142. 41. M.P. van Iersel, W.P.J. Witjes, J.J.M.C.H. de la Rosette, G.O.N. Oosterhof. Prostate-specific antigen density: correlation with histological diagnosis of prostate cancer, benign prostatic hyperplasia and prostatitis. Br J Urol 1995; 76: 47-53. 42. R.G. Aarnink, R.J.B. Giesen, J.J.M.C.H. de la Rosette, A.L. Huynen, F.M.J. Debruyne, H. Wijkstra. Planimetric volumetry of the prostate: how accurate is it? Physiol Meas 1995; 6:141-150. 43. Tubaro, S.St.C. Carter, J.J.M.C.H. de la Rosette, K Hofner, A. Trucchi, C. Ogden, L. Miano, M. Valenti, U. Jonas, F.M.J Debruyne. The prediction of clinical outcome from transurethral microwave thermotherapy by pressure-flow analysis: a european multicenter study. J Urol 1995; 153:1526-1530. 44. R.J.B. Giesen, A.L. Huynen, J.J.M.C.H. de la Rosette, H.E. Schaafsma, R.G. Aarnink, F.M.J. Debruyne, H. Wijkstra. Ultranonic computer imaging of the prostate, correlation between longitudinal and transverse texture description. Eur J Ultrasound 1995; 2: 145-149. Curriculum Vitae 8 J. de la Rosette 45. J. Donovan, H. Kay, P. Abrams, J.J.M.C.H. de la Rosette, S Brookes, A.C. Kinn and the ICS-BPH study Group. Measuring Quality of life in men with urinary symptoms: using the SF-36.Neurourology and urodynamics 1995; 14:559-560. 46. M. Devonec, S.St.C. Carter, A Tubaro, J.J.M.C.H. de la Rosette, K Hofner, P. Perrin. Microwave therapy. Current Opinion 1995; 5: 3-9. 47. R.J.B Giesen, A.L. Huynen, R.G. Aarnink, J.J.M.C.H. de la Rosette, C. van de Kaa, G.O.N Oosterhof, F.M.J Debruyne, H. Wijkstra. Computer analysis of transrectal ultrasound images of the prostate for the detection of carcinoma: a prospective study in radical prostatectomy specimens. J Urol 1995; 154: 1397-1400. 48. R.G. Aarnink, A.L. Huynen, R.J.B. Giesen, J.J.M.C.H. de la Rosette, F.M.J. Debruyne, H. Wijkstra. Automated prostate volume determination with ultrasonographic imaging. J Urol 1995; 153:1549-1554. 49. M.J.A.M. de Wildt, A. Tubaro, K Hofner, S.St.C. Carter, J.J.M.C.H. de la Rosette, M. Devonec. Responders and nonresponders to transurethral microwave thermotherapy: a multicenter retrospective analysis. J Urol 1995; 54:1775-1778. 50. E. te Slaa, A.F. van Ettergem, C.A. van „t Hof, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Durability of laser fibers. World J Urol 1995; 13: 83-87. 51. A.Cannon, M. de Wildt, P.H. Abrams, J.J.M.C.H. de la Rosette. Urodynamics and laser prostatectomy. World J Urol 1995; 13:134-136. 52. E. te Slaa, M.J.A.M. de Wildt, P.F.W.M. Rosier, H. Wijkstra, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Urinary tract infections following laser prostatectomy: is there a need for antibiotic prophylaxis? Br J Urol 1995; 76: 604-610. 53. E. te Slaa, M.J.A.M. de Wildt, P.F.W.M. Rosier, H. Wijkstra, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Urodynamic assessment in the laser treatment of benign prostatic enlargement. Br J Urol 1995; 76: 604-610. 54. P.F.W.M. Rosier, M.J.A.M. de Wildt, F.M.J. Debruyne, H. Wijkstra, J.J.M.C.H. de la Rosette. Outcome of treatment of patients with lower urinary tract symptoms that are categorized „moderately obstructed‟, according to the L-PURR classification and „not-obstructed‟ according to urethral resistance factor. Neurourology and urodynamics 1995; 14: 562-564. 55. M.J.A.M. de Wildt, E. te Slaa, P.F.W.M. Rosier, H. Wijkstra, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Urodynamic results of laser treatment in patients with benign prostatic hyperplasia. Can outlet obstruction be relieved? J. Urol 1995; 154: 174-180. 56. P.F. Rosier, J.J.M.C.H de la Rosette, H. Wijkstra, P.E. Van Kerrebroeck, F.M.J. Debruyne. Is detusor instability in elderly males related to the grade of obstruction? Neurourol Urodyn 1995; 14(6): 625-633. Curriculum Vitae 9 J. de la Rosette 57. J.J.M.C.H. de la Rosette, J.M. Fitzpatrick. The laser in the management of benign prostatic hyperplasia. World J Urol 1995; 13(2): 73. 1996: 58. E. Te Slaa, M.J.A.M. de Wildt, F.M.J. Debruyne, R. De Graaf, J.J.M.C.H. de la Rosette. Urinary tract infections following laser prostatectomy: is there a need for antibiotic prophylaxis. Br.J.Uro 1996; 77: 228. 59. M.J.A.M. de Wildt, M. Hubregtse, G. Ogden, S.S.C. Carter, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. A 12-months study of the placebo effect in transurethral microwave thermotherapy. Br.J.Urol 1996; 77: 221. 60. P.F.W.M. Rosier, M.J.A.M. de Wildt, F.M.J. Debruyne, H. Wijkstra, J.J.M.C.H. de la Rosette. Evaluation of detrusor activity during micturition in patients with benign prostatic enlargement with a clinical nomogram. J. Urol 1996; 156: 473-479. 61. J.J.M.C.H. de la Rosette, W.P.J. Witjes, F.M.J. Debruyne, P.L. Kersten, H. Wijkstra. Improved reliability of uroflowmetry investigations: results of a portable home-based flowmetry study. Br.J.Urol. 1996; 78: 385-390. 62. J.J.M.C.H. de la Rosette. Evaluatie van de mictie met behulp van uroflowmetry: het gebruik van een portable homeflowmeter. Profundum 1996; 3: 24-27. 63. J.J.M.C.H. de la Rosette, M.J.A.M. de Wildt, K. Hofner, S.St.C. Carter, F.M.J. Debruyne, A. Tubaro. Pressure/flow study analysis in patients treated with High Energy Thermotherapy (Prostasoft 2.5). J.Urol. 1996; 156: 1428-1433. 64. J.J.M.C.H. de la Rosette, M.J.A.M. de Wildt, K Hofner, S.St.C. Carter, F.M.J. Debruyne, A. Tubaro. High energy thermotherapy in the treatment of benign prostatic hyperplasia. Results of the European BPH study group. J.Urol. 1996; 156: 97-102. 65. R. Muschter, J.J.M.C.H. de la Rosette, H. Whitfield, J-P Pellerin, S. Madersbacher and D. Gillatt. Initial Human Clinical Experience with Diode Laser Interstitial Treatment of BPH. Urology 1996; 48: 223-228. 66. R.G. Aarnink, J.J.M.C.H. de la Rosette, F.M.J. Debruyne, H. Wijkstra: Reproducibility of transrectal ultrasound of the prostate concerning planimetric volume determinations. Br. J. Urol. 1996; 78: 219-223. 67. R.G. Aarnink, J.J.M.C.H. de la Rosette, F.M.J. Debruyne, H. Wijkstra. Formula derived prostate volume determination. Eur Urol 1996; 29: 399-402. 68. R.G. Aarnink, J.J.M.C.H. de la Rosette, A.L. Huynen, R.J.B. Giesen, F.M.J. Debruyne, H. Wijkstra. Standardized assessment to enhance the diagnostic value of prostate volume, Part I: morphometry in patients with lower urinary tract symptoms. The Prostate 1996; 9(5): 317-326. Curriculum Vitae 10 J. de la Rosette 69. R.G. Aarnink, J.J.M.C.H. de la Rosette, A.L. Huynen, R.J.B. Giesen, F.M.J. Debruyne, H. Wijkstra. Standardized assessment to enhance the diagnostic value of prostate volume, Part II: correlation with PSA levels. The Prostate 1996; 29(5): 327333. 70. E. te Slaa, J.J.M.C.H. de la Rosette. Lasers in the treatment of benign prostatic obstruction: past, present and future. Eur. Urol. 1996; 30: 1-10. 71. P.F.W.M. Rosier, J.J.M.C.H. de la Rosette, H. Wijkstra, Ph.E.V.A. van Kerrebroeck, F.M.J. Debruyne. Is detrusor instability in elderly males related to the grade of obstruction. Neuro Urol Urodyn 1996 14: 625-635. 72. P.F.W.M. Rosier, J.J.M.C.H. de la Rosette, M.J.A.M. de Wildt, F.M.J. Debruyne, H. Wijkstra. Comparison of passive urethral resistance relation and urethral resistance factor in analysis of bladder outlet obstruction in patients with benign prostatic enlargement. Neuro Urol Urodyn. 1996; 15: 1-15. 73. K. Ezz El Din, J.J.M.C.H. de la Rosette. Transrectal ultrasound of the prostate. Br.J.Urol. 1996; 78: 2-9. 74. M.J.A.M. de Wildt, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. High energy transurethral microwave thermotherapy: a thermoablative treatment for benign prostatic obstruction. Urology 1996; 48: 416-423. 75. G.J. Jager, J.O. Barentz, E.T.G. Ruijter, J.J.M.C.H. de la Rosette, G.O.N. Oosterhof. Primary staging of prostate cancer. Eur.Radiol. 1996; 6: 129-133. 76. C.F.P van Swol, E. te Slaa, R.M. Verdaasdonk, J.J.M.C.H. de la Rosette, T.A. Boon. Variation in output power of laser prostatectomy fibers: a need for power measurement. Urology 1996; 47: 672-678. 77. G.J. Jager, E.T.G. Ruijter, C.A. van de Kaa, J.J.M.C.H. de la Rosette, G.O.N. Oosterhof, J.R. Thornbury, J.O. Barentz. Local Staging of Prostate Cancer with Endorectal MR imaging: Correlation with Histopathology. A.J.R. 1996; 66: 845-852. 78. R.J.B. Giesen, A.L. Huynen, R.G. Aarnink, J.J.M.C.H. de la Rosette, F.M.J. Debruyne, H. Wijkstra. Construction and application of a hierarchical decision tree for the classification of ultrasonographic prostate images. Medical & Biological Engeneering & Computing 1996; 34:105-109. 79. W.F.R.M. Koch., K. Ezz El Din, M.J.A.M. de Wildt, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. The outcome of renal ultrasound in the assessment of 556 consecutive patients with benign prostatic hyperplasia. J Urol 1996; 155: 186-189. 80. M.P. van Iersel, C.M.G. Thomas, W.P.J. Witjes, R. de Graaf, J.J.M.C.H. de la Rosette. F.M.J. Debruyne. Clinical implications of the rise and fall of PSA after laser prostatectomy. Br.J.Urol. 1996; 78: 742-746. Curriculum Vitae 11 J. de la Rosette 81. P.F.W.M. Rosier, M.J.A.M. de Wildt, H. Wijkstra, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Clinical diagnosis of bladder outlet obstruction in patients with benign prostatic enlargement and lower urinary tract symptoms: development and urodynamic validation of a clinical prostate score for the objective diagnosis of bladder outlet obstruction. J. Urol. 1996; 155:1649-1654. 82. K. Ezz El Din, M.J.A.M. de Wildt, P.F.W.M. Rosier, H. Wijkstra, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. The correlation between urodynamic and cystoscopic findings in elderly men with voiding complaints. J Urol 1996; 155: 1018-1022. 83. K. Ezz El Din, W.F.R.M. Koch, M.J.A.M. de Wildt, L.A.L.M. Kiemeney, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Reliability of the international prostate symptom score (IPSS) in the assessment of patients with lower urinary tract symptoms and/or benign prostatic enlargement. J Urol. 1996; 155: 1959-1964. 84. A. Jardin, K.E. Andersson, C.C. Schulman, D. Graham, J.M. Buzelin, J.J.M.C.H. de la Rosette, T.Christmas, C.R. Chapple. Consensus Meeting on New approaches in the Pharmacotherapy of Benign Prostatic Hyperplasia (BPH). Eur Urol 1996; 29:374-384. 85. J.L. Donovan, P. Abrams, T.J. Peters, H.E. Kay, J. Reynard, C. Chapple, J.J.M.C.H. de la Rosette and A. Kondo. The ICS-„BPH‟Study: the psychometric validity and reliability of the ICS male questionnare. Br.J.Urol. 1996; 77: 554-562. 86. M.J.A.M. de Wildt, F.C.H. d‟Ancona, M. Hubregtse, S.St.C. Carter, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. 3 Years follow-up in patients treated with lowwer energy thermotherapy (Prostasoft version 2.0). J. Urol. 1996; 156: 1959-1963. 87. K. Ezz El Din, L.A.L.M. Kiemeney, M.J.A.M. de Wildt, P.F.W.M. Rosier, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. The correlation between uroflowmetry, prostate volume, postvoid residue and lower urinary tract symptoms as measured by the international prostate symptom score. Urology 1996; 48: 393-397. 88. E. te Slaa, J.J. Mooibroek, Th.M. de Reijke, H.F.M. Karthaus, J-W. van Capelle, N. Tjon Pian Gi, J.J.M.C.H. de la Rosette. Laser treatment of the prostate using the urolase fiber: the dutch experience. J.Urol. 1996; 156: 420-425. 89. K. Ezz El Din, L.A.L.M. Kiemeney, M.J.A.M. de Wildt, P.F.W.M. Rosier, F.M.J. Debruyne, J.J.M.C.H. de la Rosette.The correlation between bladder outlet obstruction (BOO) and lower urinary tract symptoms (LUTS) as measured by the international prostate symptom score (IPSS). J.Urol. 1996; 156: 1020-1025. 90. K. Ezz El Din, W.F.R.M. Koch, M.J.A.M. de Wildt, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. The predictive value of microscopic haematuria in patients with lower urinary tract symptoms and benign prostatic hyperplasia. Eur.Urol 1996; 30: 409-413. Curriculum Vitae 12 J. de la Rosette 91. W.P.J. Witjes, M.J.A.M. de Wildt, P.F.W.M. Rosier, C.T.M. Caris, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Variability of clinical and pressure-flow study variables after 6 months of watchful waiting in patients with lower urinary tract symptoms and benign prostatic enlargement. J. Urol.1996; 156: 1026-1034. 92. R.G. Aarnink, J.J.M.C.H. de la Rosette, F.M.J. Debruyne, H. Wijkstra. Computerised interpretation of ultrasonographic prostate images in the early diagnosis of prostate cancer - the AUDEX system. Oncology in practice1996; 2/96: 11-13. 93. R.G. Aarnink, A.L. Huynen, R.J.B. Giesen, J.J.M.C.H. de la Rosette, F.M.J. Debruyne, H. Wijkstra. Automated prostate volume determination with ultrasonographic imaging. J Urol 1996; 155: 1038. 94. W.P.J. Witjes, P.F.W.M. Rosier, M.J.A.M. de Wildt, M.P. van Iersel, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Urodynamic and clinical effects of terazosin therapy in patients with symptomatic benign prostatic hyperplasia. J Urol 1996; 155: 1317. 95. R.G. Aarnink, J.J.M.C.H. de la Rosette, F.M.J. Debruyne, H. Wijkstra. Formula derived prostate volume determination. Eur Urol 1996; 29(4): 399. 96. G.J. Jager, J.O. Barentz, E.T. Ruijter, J.J.M.C.H. de la Rosette, G.O.N. Oosterhof. Primary staging of prostate cancer. Eur Radiol 1996; 6(2): 134-139. 99. J.L. Donovan, P. Abrams, T.J. Peters, H.E. Kay, J. Reynard, C. Chapple, J.J.M.C.H. de la Rosette, A. Kondo, ICS”BPH” Study group. The ICS -”BPH” study: The psychometric validity and reliability of ICSmale questionnaire. Br.J.Urol 1996; 77: 554-562. 1997: 100. F.C.H. d‟Ancona, E.A.E. Francisca, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. High energy transurethral microwave thermotherapy in the treatment of patients with lower urinary tract symptoms. J Endo urol 1997; 11(4): 285-289. 101. W.P.J. Witjes, J.J.M.C.H. de la Rosette, J.L. Donovan, T.J. Peters, P. Abrams, H.E. Kay, K. Hofner, A.C. Kinn, S. Walter, ICS-”BPH” study group. The ICS”BPH” study: International differences in lower urinary tract symptoms and related bother. J Urol 1997; 157: 1295-1300. 102. J.J.M.C.H. de la Rosette, H.P. Beerlage, F.M.J. Debruyne. Role of Temporary stents in alternative treatment of benign prostatic hyperplasia. J Endorurol 1997; 11(6): 467-472. Curriculum Vitae 13 J. de la Rosette 103. J.L. Donovan, H.E. Kay, T.J. Peters, P. Abrams, J. Coast, A. Matos-Ferreira, L. Rentzhog, J.L.H.R. Bosch, J. Nordling, J.B. Gajewski, G. Barbalias, E. Schick, M. Mendes Silva, I. Nissenkorn, J.J.M.C.H. de la Rosette. Using the ICSQol to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS-BPH study. Br. J. Urol. 1997; 80: 712-721. 104. T.J. Peters, J.L. Donovan, H.E. Kay, P. Abrams, J.J.M.C.H. de la Rosette, D. Porru, J.W. Thuroff and the international continence society “BPH” study group. The international continence society “benign Prostatic Hyperplasia” study: the bothersomeness of urinary symptoms. J. Urol 1997; 157: 885-889. 105. G. Jager, E. Ruijter, J.J.M.C.H. de la Rosette, C. Van de Kaa. Amyloidosis of the Seminal Vesicles Simulating Tumor Invasion of Prostatic Carcinoma on Endorectal MR Images. Eur Radiol 1997; 7(4): 552-454. 106. G. Jager, E. Ruijter, C. van de Kaa, J.J.M.C.H. de la Rosette, G. Oosterhof, J. Thornbury, J. Ruijs, J. Barentsz. Dynamic Turbo-FLASH Subtraction Technique for Contrast-enhanced MR images of the Prostate: Correlation with Histopathology. Genitourinary radiology 1997; 203: 645-652. 107. A. Heerschap, G. Jager, M. van der Graaf, J. Barentsz, J.J.M.C.H. de la Rosette, G. Oosterhof, E. Ruijter, J. Ruijs. In-vivo Proton MR Spectroscopy Reveals Altered Metabolic Content in Malignant Prostate Tissue.Anticancer Res1997; 17: 1455-1460. 108. P. Abrams, J. Donovan, J.J.M.C.H. de la Rosette, W. Schäfer and the ICS-‟BPH‟ study group. The international continence society “BPH” study: background, aims and methodology. Neurourol and Urodynam 1997; 16(2): 79-92. 109. E. te Slaa, E.A.E. Francisca, J.C.M. Hendriks, L.A.L.M. Kiemeney, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Quality of life assessment in patients following laserprostatectomy. Br. J Urol 1997; 80: 211-216. 110. J.J.M.C.H. de la Rosette, F.C.H. d‟Ancona, F.M.J. Debruyne. Current status of thermotherapy treatment of the prostate. J Urol 1997; 157: 430-438. 111. F.C.H. d‟Ancona, E.A.E. Francisca, W.P.J. Witjes, L. Welling, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. High energy thermotherapy (TUMT) versus transurethral resection (TURP) in the treatment of benign prostatic hyperplasia (BPH): results of a prospective randomized study with a 1-year follow-up. J Urol 1997; 158: 120-125. 112. K. Ezz El Din, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Making the diagnosis of benign prostatic hyperplasia (BPH): a critical review. Eur Urol 1997; 31: 257-262. 113. R. Aarnink and J.J.M.C.H. de la Rosette. A preprocessing algorith for edge detection with multiple scale of resolution. European Journal of Ultrasound 1997; 5: 113-126. Curriculum Vitae 14 J. de la Rosette 114. W.P.J. Witjes, P.F.W.M. Rosier, C.T.M. Caris, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Urodynamic and clinical effects of terazosin therapy in symptomatic patients with and without bladder outlet obstruction: a stratified analysis. Urology 1997; 49: 197-206. 115. W.P.J. Witjes, R.G. Aarnink, K. Ezz-El-Din, H. Wijkstra, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. The correlation between prostate volume, transition zone volume, transition zone index and clinical and urodynamic investigations in patients with symptomatic benign prostatic hyperplasia. Br. J Urol 1997; 80: 84-90. 116. E.A.E. Francisca, F.C.H. d‟Ancona, J.C.M. Hendriks, L.A.L.M. Kiemeney, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Quality of life assessment in patients treated with lower energy thermotherapy (Prostasoft 2.0): results of a randomized TUMT versus SHAM study. J Urol 1997; 158: 1839-1844. 117. J.J.M.C.H. de la Rosette, R. Muschter, M.A. Lopez, D. Gillatt. Interstitial laser coagulation (ILC) in the treatment of benign prostatic hyperplasia (BPH) using a diode laser system with temperature feedback. Br.J.Urol 1997; 80: 433-438. 118. Bierkens, A. Hendrikx, K. Ezz El Din, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. The value of antibiotic prophylaxis during extracorporeal shock wave lithotripsy in the prevention of urinary tract infections in patients with proven sterile urine prior to treatment. Eur. Urol.1997; 31: 30-35. 119. Y. Xue, F. Smedts, R. Umbas, T.W. Aalders, F.M.J. Debruyne, J.J.M.C.H. de la Rosette, J.A. Schalken. Changes in keratin expression during the development of benign prostatic hyperplasia (BPH). Eur Urol 1997; 32: 332-338. 120. Yong Xue, Albert Verhofstad, Wil Lange, Frank Smedts, Frans M.J. Debruyne, J.J.M.C.H. de la Rosette, Jack Schalken. Prostatic Neuroendocrine Cells Have a Unique Keratin Expression Pattern and Do Not Express Bcl-2 --- cel kinetic features of neuroendocrine cells in human prostate. Am J Pathol 1997; 151 (6): 1759-1765. 121. Wim P.J. Witjes, H. Wijkstra, Frans M.J. Debruyne, J.J.M.C.H. de la Rosette. Quantitative assessment of uroflow: is there a circadian rhythm? Urology 1997; 50: 221-228. 122. Wim P.J. Witjes, Andrew robertson, Peter F.W.M. Rosier, David E. Neal, Frans M.J. Debruyne, J.J.M.C.H. de la Rosette. Urodynamic and clinical effects of noninvasive and minimally invasive treatments in elderly men with lower urinary tract symptoms stratified according to the grade of obstruction. Urology 1997; 50: 55-61. 123. R.G. Aarnink, J.J.M.C.H. de la Rosette, Wouter F.J. Feitz, Frans M.J. Debruyne, H. Wijkstra. A preprocessing algorithm for edge detection with multiple scales of resolution. European Journal of Ultrasound 1997; 5:113-126. Curriculum Vitae 15 J. de la Rosette 1998: 124. J.J.M.C.H. de la Rosette, M. Blute, F. Degrandchamps. Transurethral thermotherapy using the Prostatron device. World J Urol 1998; 16(2):89-96. 125. E.A.E. Francisca, M. Blute, J.J.M.C.H. de la Rosette. Quality of life in TUMT. World J. Urol 1998; 16(2):148-153. 126. H.P. Beerlage, Th. De Reijke, J.J.M.C.H. de la Rosette. Considerations regarding prostate biopsies. Eur urol 1998; 34: 303-312. 127. H.P. Beerlage, E.A.E. Francisca, F.C.H. d‟Ancona, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Urolase versus ultraline fibers in laser prostatectomy; 3 year follow up of a prospective randomized study. J Endodurol 1998; 12 (nr 6), 575-580. 128. Frank C.H. d‟Ancona, Elmer A.E. Francisca, Wim P.J. Witjes, L. Welling, Frans M.J. Debruyne, J.J.M.C.H. de la Rosette. Transurethral resection of the prostate (TURP) versus high energy thermotherapy (HE-TUMT) of the prostate in patients with benign prostatic hyperplasia (BPH): long-term results. Br.J Urol 1998; 81(2): 59264. 129. F.C.H. d‟Ancona, E.A.E. Francisca, J.C.M. Hendriks, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. The predictive value of baseline variables in the treatment of benign prostatic hyperplasia using high energy transurethral microwave thermotherapy. Br. J Urol 1998; 82: 808-813. 130. J.J.M.C.H. de la Rosette, W.P.J. Witjes, W. Schafer, P. Abrams, J.L. Donovan, T.J. Peters, R.J. Millard, C Frimodt-Moller, P. Kalomiris and the ICS-BPH study group. The relationship between lower urinary tract symptoms and bladder outlet obstruction: Results from the ICS-BPH study. Neurourol 1998;17: 99-108. 131. Y. Xue, J. Lie, M.A.H.E. Latijnhouwers, F. Smedts, R. Umbas, T.W. Aalders, F.M.J. Debruyne, J.J.M.C.H. de la Rosette, J.A. Schalken. Expression of periglandular tenascin-C and basement membrane laminin in normal prostate, benign prostatic hyperplasia and prostate carcinoma. Br. J Urol 1998; 81: 844-851. 132. Y. Xue, F. Smedts, A. Verhofstad, F.M.J. Debruyne, J.J.M.C.H. de la Rosette, J.A. Schalken. Cell kinetics of prostate exocrine and neuroendocrine epithelium and their differential interrelationships: new perspectives. Prostate 1998;8: 62-73. 133. G.B.J.M. Keijzers, E.A.E. Francisca, F.C.H. d‟Ancona, L.A.L.M. Kiemeney, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Long-term Results of Lower Energy TUMT (Prostasoft 2.0). J Urol 1998; 159: 1966-1973. 134. E. te Slaa, C.F.P. van Swol, T.A. Boon, R.M. Verdaasdonk, W.H. Doesburg, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. The influence of the decay of laser fibers during laser prostatectomy on the clinical results. J Endourol 1998; 12(3): 291-295. Curriculum Vitae 16 J. de la Rosette 135. J. Van Drongelen, L.A.L.M. Kiemeney, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. The impact of urometabolic evaluation on the prevention of urolithiasis: a retrospective study. Urology 1998; 52(3), 384-391. 136. R.G. Aarnink, H.P. Beerlage, J.J.M.C.H. de la Rosette, Frans M.J. Debruyne, H. Wijkstra. Transrectal Ultrasound of the prostate: innovations and future applications, J Urol. 1998 ,159: 1568-1579. 137. Y.Xue, F. Smedts, F.M.J. Debruyne, J.J.M.C.H. de la Rosette, J.A. Schalken. Identification of intermediate cell types by keratin expression in the developing human prostate. The prostate 1998; 34(4): 292-301. 138. Y. Xue, W. Lange, F. Smedts, F. Debruyne, J.J.M.C.H. de la Rosette, J Schalken, A. Verhofstad. A novel immunoenzymatic technique to demonstrate multiple antigens in cells based on selective destaining of reaction products and its application in characterizing the immunophenotype of neuroendocrine cells in the human prostate. Applied immunihistochemistry 1998; 6(2): 69-76. 139. A. Tubaro, J.J.M.C.H. de la Rosette, K. Hofner, A. Trucchi, and S.St.C. Carter. Correlation amongst objective and subjective parameters of bladder outlet obstruction in the clinical response to microwave thermotherapy. Urodinamica , 1998; 8: 200-210. 140. J.M. Reynard, Q Yang, J.L. Donovan, T.J. Peters, W. Schafer, J.J.M.C.H. de la Rosette, N.F. Dabhoiwala, D Osawa, A. Tong Long Lim, P. Abrams. The ICS„BPH‟ Study: uroflowmetry, lower urinary tract symptoms and bladder outlet obstruction. Br. J Urol 1998; 82: 619-623. 141. K. Hofner, A Tubaro, J.J.M.C.H. de la Rosette, S.St.C. Carter. Analysis of Outcome After Thermotherapy Using Different Classifications of Bladder Outlet Obstruction. Neurourol and Urodyn 1998; 17: 109-120. 142. J. Donovan, S. Brookes, P. Abrams, J.J.M.C.H. de la Rosette. Are symptoms of incontinence in men relieved by treatment for bladder outlet obstruction?: data from the ICS-„BPH‟ study. Neurourol urodyn 1998; 17: 363-365. 143. R.G. Aarnink, S.D. Pathak, J.J.M.C.H. de la Rosette, F.M.J. Debruyne, Y. Kim, H. Wijkstra. Edge detection in prostatic ultrasound images using integrated edge maps. Ultrasonics 1998; 36: 635-642. 144. A.F. Bierkens, A.J.M. Hendrikx, J.J.M.C.H. de la Rosette, G.N.M. Stultiens, H.P. Beerlage, A.J. Arends, F.M.J. Debruyne. Treatment of mid-and lower ureteric calculi: extracorporeal shock-wave lithotrypsie vs laser ureteroscopy. A comparison of costs, morbidity and effectiveness. Br. J. Urol 1998; 81: 31-35. 145. Y. Xue, F. Smedts, M.A.H.E. Lathouwers, E.T.H. Ruijter, T.W. Aalders, J.J.M.C.H. de la Rosette, F.M.J. Debruyne, J.A. Schalken. Tenascin-C Expression in Prostatic Intraepithelial Neoplasia (PIN): a marker of Progression? Anticancer Research 1998; 18: 2679-2684. Curriculum Vitae 17 J. de la Rosette 146. W.P. Witjes, J.J.M.C.H. de la Rosette, M. Zerbib, G.C. Vignoli, C. Geffriaud, F.M.J. Debruyne, H. Wijkstra.Computerized artifact detection and correlation of uroflow curves: towards a more consistent quantitative assessment of maximum flow. Eur. Urol 1998; 33(1): 54-63. 148. D. Floratos, J.J.M.C.H. de la Rosette. The value of urodynamics in laser Prostatectomy. Eur Urol 1998; (37): 509-516. 1999: 149. H.P. Beerlage, G.J.L.H. van Leenders, G.O.N. Oosterhof, J.A. Witjes, E.T. Ruijter, C.A. van de Kaa, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. High intensity focused ultrasound (HIFU) followed after on to two weeks by radical retropubic prostatecomy: results of a prospective study. Prostate 1999; 39(1): 41-46. 150. F.C.H. D'Ancona, A.K. van der Bij, E.A. Francisca, H. Kho, F.M.J. Debruyne, L.A. Kiemeney, J.J.M.C.H. de la Rosette. Results of high-energy transurethral microwave thermotherapy in patients categorized according to the American Society of Anesthesiologists operative risk classification. Urology 1999; 53(2): 322-328. 151. F.C. d'Ancona, Y.H. Albers, L.A. Kiemeney, Y. Xue, F. Smedts, H.G. van der Poel, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Can histopathology predict treatment outcome following high-energy transurethral microwave thermotherapy of the prostate. Results of a biopsy study. Prostate 1999; 40(1): 28-36. 152. H.P. Beerlage, S. Thuroff, F.M.J. Debruyne, C. Chaussy, J.J.M.C.H. de la Rosette. Transrectal high-intensity focused ultrasound using the Ablatherm device in the treatment of localized prostate carcinoma. Urology 1999; 54(2): 273-277. 153. J.T. Bousema, M.J.G. Bussemakers, K.P. van Houwelingen, F.M.J. Debruyne, J.J.M.C.H. de la Rosette, L.A. Kiemeney. Polymorphisms in the vitamin D receptor gene and androgen receptor gene and the risk of benign prostatic hyperplasia. Eur Urol 1999; (37): 234-238. 154. G.S. Sonke, L.A.L.M. Kiemeney, A.L.M. Verbeek, B.B.M. Kortmann, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Low Reproducibility of Maximum Urinary Flow Rate Determined by Portable Flowmetry. Neurourol and Urodyn 1999; (18): 183-191. 155. A. Martenson, J.J.M.C.H. de la Rosette. Interstitial Laser coagulation in the treatment of BPH using a diode laser system: Results of an evolving technology. Prostate Cancer and Prostatic Diseases 1999; (2): 148-154. 156. E.A.E. Francisca, G.B.J.M. Keijzers, F.C.H. d‟Ancona, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Lower energy thermotherapy (TUMT 2.0) in the treatment of BPH: Long term follow up results of a multicenter international study. World J. Urol 1999; (17): 279-284. 157. D.L. Floratos, J.J.M.C.H. de la Rosette. Lasers in Urology. Br.J.Urol 1999; (84): 204-211. Curriculum Vitae 18 J. de la Rosette 158. R.G. Aarnink, H.P. Beerlage, J.J.M.C.H. de la Rosette, F.M.J. Debruyne, H. Wijkstra. Contrast Angiosonography: A technology to Improve Doppler Ultrasound Examinations of the Prostate. Eur Urol 1999; (35): 9-20. 159. J.L. Donovan, S.T. Brookes, J.J.M.C.H. de la Rosette, T.J. Peters, D. Porru, A. Kondo, N. Dabhoiwala, R. Millard, R. Bosch, J. Nordling, A. Matos Ferreira, K. Hofner, H. Mostafid, S. Walter, I. Nissenkorn, C. Frimodt Moller, M. Mendes Silva, C. Chapple, P. Abrams. The responsiveness of the ICSmale questionnaire to outcome: evidence from the ICS-„BPH‟ study. BJU International 1999; (83): 243248,. 160. Yong Xue, Jeroen A.W.M. van der Laak, Mieke Latijnhouwer, Henk G. Van der Poel, J.J.M.C.H. de la Rosette, Frans M.J. Debruyne, Jack A. Schalken. Transient Tenascin Enhancement is an early event after Androgen Ablation in Rat Prostate. Urol. 1999; Res 27,9-15. 161. E.A.E. Francisca, F.C.H. d‟Ancona, E.J.H. Meuleman, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Sexual function following high energy microwave thermotherapy: results of a randomized controlled study comparing transurethral microwave thermotherapy to transurethral prostatic resection. J Urol 1999; (161) 486-490. 162. J.J.M.C.H. de la Rosette and A.R. Zlotta. Alternatives treatment in BPH: Future perspectives. Eur Urol 1999; 35(2), 173-176. 163. H.A. Bogers, J.P.M. Sedelaar, H.P. Beerlage, J.J.M.C.H. de la Rosette, F.M.J. Debruyne, H. Wijkstra, R.G. Aarnink. Contrast-enhanced 3D Power Doppler Angiography of the human prostate: correlation with biopsy outcome. Urology 1999; 54(1), 97-104. 164. F.C.H. d‟Ancona, E.A.E. Francisca, J.C.M. Hendriks, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. How to select patients for high energy transurethral microwave thermotherapy. Urology 1999; 53(1), 111-117. 165. F.C.H. d‟Ancona, J.J.M.C.H. de la Rosette. Future perspectives of transurethral microwave thermotherapy. Prostatic disease 1999; 3(2), 29-31. 166. B.B.M. Kortmann, G.S. Sonke, F.C.H. d‟Ancona, D.L. Floratos, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. The tolerability of urodynamic studies and flexible cystourethroscopy used in the assessment of men with lower urinary tract symptoms. BJU International 1999; (84): 449-453. 167. J.O. Barentsz, M.R.W. Engelbrecht, J.A.M. Witjes, J.J.M.C.H. de la Rosette, M. van der Graaf. MR Imaging of the male Pelvis. Review article. Eur Radiol 1999 (9): 1722-1736. 2000: 168. Y Xue, J. van der Laak, F. Smedts, C. Schoots, J. Schalken, A Verhofstadt, J.J.M.C.H. de la Rosette. Neuroendocrine cells during human prostate development: does neuroendocrine cells density remain constant during fetal as well as postnatal life? Prostate 2000; 42(2):116-123. Curriculum Vitae 19 J. de la Rosette 169. G.J.L.H. van Leenders, H.P. Beerlage, E.Th. Ruijter, J.J.M.C.H. de la Rosette, C.A. van de Kaa and D.J. Ruiter. Histopathologic changes associated with High Intensity Focused Ultrasound (HIFU) therapy for localized adenocarcinoma of the prostate. J. Clin Pathol 2000 (53): 391-394. 170. J.J.M.C.H. de la Rosette, E.A.E. Francisca, B.B.M Kortmann, D.L. Floratos, L.A.L.M. Kiemeney, F.M.J. Debruyne. Clinical efficacy of a new 30-minutes algorithm for transurethral microwave thermotherapy (TUMT 3.5): initial results. BJU International 2000 (86): 47-51. 171. G.S. Sonke, T. Heskes, A.L. Verbeek, J.J.M.C.H. de la Rosette, L.A. Kiemeney. Prediction of bladder outlet obstruction in men with lower urinary tract symptoms using artificial neural networks.J Urol 2000; 163(1):300-305. 172. J.P.M. Sedelaar, R.G. Aarnink, G.J.L.H van Leenders, H.P. Beerlage, F.M.J. Debruyne, H. Wijkstra, J.J.M.C.H de la Rosette. The application of threedimensional contrast enhanced ultrasound to measure volume of affected tissue after HIFU treatment for localized prostate cancer. Eur Urol, 2000 37(5): 559-568. 173. B.B.M. Kortmann, G.S. Sonke, H. Wijkstra, J. Nordling, E. Kallestrup, N.R. Holm, J.J.M.C.H. de la Rosette. Intra-and inter-investigator variation in the analysis of pressure-flow studies in men with lower urinary tract symptoms. Neurourol & Urodyn 2000 (19): 221-232. 174. D.L. Floratos, G.S. Sonke, E.A.E. Francisca, L.A.L.M. Kiemeney, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Long-term follow up of laser treatment for lower urinary tract symptoms of bladder outlet obstruction. Urology 2000; 163(5): 1457-1460. 175. D. Unal, J.P.M. Sedelaar, R.G. Aarnink, G.J.L.H. van Leenders, H. Wijkstra, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Three dimensional contrast enhanced power Doppler ultrasound and conventional examination methods: value of diagnostic predictors of prostate cancer. BJU International 2000 (86): 58-64. 176. J.J.M.C.H. de la Rosette. What we do and don‟t know about benign prostatic hyperplasia. Curr Opin Urol 10:1-2, 2000. 177. J.J.M.C.H. de la Rosette, M.P. Laguna, G. Pace, B.B.M. Kortmann, O. Selvaggio, F.M.J. Debruyne, F.P. Selvaggi. Efficacy and Safety of the New High Energy 30 minute transurethral Microwave Thermotherapy: Results of 1 Year follow up in a multicenter study. Techniques in Urology 2000; 6(4):271-275.. 178. D.L. Floratos, G.J. Alivizatos, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Transurethral Microwave Thermotherapy in the Armamentarium of Therapeutic Modalities for Benign Prostatic Hyperplasia. Techniques in Urology 2000; 6(4):256261. 179. G.S. Sonke, B.B.M. Kortmann, A.L.M. Verbeek, L.A.L.M. Kiemeney, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Variability of Pressure Flow Studies in Men with Lower Urinary Tract Symptoms. Neurourology and Urodynamics 2000 (19): 637-656. Curriculum Vitae 20 J. de la Rosette 180. J.L. Donovan, T.J. Peters, P. Abrams, S.T. Brookes, J.J.M.C.H. de la Rosette, W. Schafer. Scoring the short form ICS male SF Questionnaire. J Urol 2000 (164): 1948-1955. 181. M.R.W. Engelbrecht, J.O. Barentsz, G.J. Jager, M van der Graaf, A. Heerschap, J.P.M. Sedelaar, R.G. Aarnink, J.J.M.C.H. de la Rosette. Prostate cancer staging using imaging. BJU International 2000(86) suppl 1: 123-134. 182. E.A.E. Franciscs, B.B.M. Kortmann, D.L. Floratos, L.A.L.M. Kiemeney, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Tolerability of 3.5 versus 2.5 High Energy Transurethral Microwave Thermotherapy. Eur Urol 2000 (38): 59-63. 183. D.L. Floratos, G.S. Sonke, E.A.E. Francisca, L.A.L.M. Kiemeney, B.B.M. Kortman, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. High energy transurethral microwave thermotherapy for the treatment of patients in urinary retention. J Urol 2000 (163): 1457-1460. 184. G.J. Jager, J.L. Severens, J.R. Thornbury, J.J.M.C.H. de la Rosette, S.H.J. Ruijs, J.O. Barentsz. Prostate Cancer Staging: Should MR Imaging be used? A decision analytic approach. Radiology 2000(215): 445-451. 185. E.A.E. Francisca, F.C. d‟Ancona, J.C. Hendriks, L.A. Kiemeney, F.M. Debruyne, J.J.M.C.H. de la Rosette. A randomized study comparing high-energy TUMT to TURP: quality of life aspects. Eur Urol 2000; 38(5): 569-575. 186. M. Bolmsjo, S. Schelin, L. Wagrell, T. Larson, J.J.M.C.H. de la Rosette, A. Mattiasson. Cell-kill modelling of microwave thermotherapy for treatment of BPH. J Endourol 2000; 14(8): 627-635. 187. G.S. Sonke, D. Kolman, J.J.M.C.H. de la Rosette, L.H.C. Donkers, P. Boyle, A.L.M. Kiemeney. Prevalentie van lagere urinewegsymtomen bij mannen en de invloed op hun kwaliteit van leven: het Boxmeer-onderzoek. NTVG 2000 144(53): 2558-2563. 188. D.L. Floratos, G.S. Sonke, E.A.E. Francisca, L.A.L.M. Kiemeney, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Long-term follow-up of laser treatment for lower urinary tract symptoms suggestive of bladder outlet obstruction. Urology 2000 56(4): 604609. 190. D.L. Floratos, G.J. Alivizatos, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. TUMT in the armamentarium of therapeutic modalities for 'BPH'. Tech urol. 2000 6(4): 256261. review. 2001: 191. J.P.M. Sedelaar, G.J.L.H. van Leenders, C.A.Hulsbergen-van de Kaa, H.G. van der Poel, J.A.W.M. van der Laak, F.M.J. Debruyne, H. Wijkstra, J.J.M.C.H. de la Rosette. Microvessel Density: Correlation between Contrast Ultrasonography and Histology of Prostate Cancer. Eur Urol 2001; (40) 285-293. 192. C. Roehrborn, G. Bartsch, R. Kirby, J Andriole, P. Boyle, J. de la Rosette, P. Perrin, E. Ramsey, J. Nordling, G.de Campos Freire, S. Arap. Guidelines for the diagnosis and treatment of benign prostatic hyperplasia: a comparative international overview. Urology 2001; (58): 642-650. Curriculum Vitae 21 J. de la Rosette 193. M.P. Laguna, J.J.M.C.H. de la Rosette. The endoscopic approach to the distal ureter in nephroureterectomy for upper urinary tract tumor. J Urol 2001; (166-6): 2017-2022. 194. D.L. Floratos, J.J.M.C.H. de la Rosette. Heat treatment of the prostate: where do we stand in 2000? Current Opinion in Urology 2001; (11): 35-41. 195. S.P.C. Souverein, R.M.C. Herings, J.J.M.C.H. de la Rosette, A.J. Man in „t Veld, R.D. Farmer, H.G.M. Leufkens. Evaluating adverse cardiovascular effects of drug treatment for Benign Prostatic Hyperplasia (BPH): methodological considerations. Journal of Clinical Epidemiology 2001; (54): 518-524. 196. D.L. Floratos, L.A.L.M. Kiemeney, C. Rossi, B.B.M. Kortmann, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Long-term follow up of a randomized TUMT versus TURP study. J Urol 2001 (165): 1533-1538. 197. J.J.M.C.H. de la Rosette, R.G. Aarnink. New Developments in Ultrasonography for the Detection of Prostate cancer. J Endourol 2001(15): 93-104. 198. B.S. Wadie, E-H. E. Ibrahim, J.J.M.C.H. de la Rosette, M.A. Gomha, M.A. Ghoneim. The relationship between IPSS and the objective parameters in the diagnosis of BOO: Part I: when statistics fail. J Urol 2001; 165(1): 32-34. 199. P. Minnee, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Transurethral Microwave Thermotherapy in Benign Prostatic Hyperplasia. Current Opinion in Urology 2001. 200. C. Rossi, B.B.M. Kortmann, G.S. Sonke, D.L. Floratos, L.A.L.M. Kiemeney, H. Wijkstra, J.J.M.C.H. de la Rosette. Alpha-blockade improves symptoms suggestive of bladder outlet obstruction (BOO) but fails to relieve BOO itself. J Urol 2001; (165): 38-41. 201. F. Yue, E. Smedts, Th. Ruijter, F.M.J. Debruyne, J.J.M.C.H. de la Rosette, J.A. Schalken. Branching activity in the Human Prostate: a closer look at the structure of small glandular buds. Eur Urol 2001; (39-2): 222-231. 202. J.P.M. Sedelaar, T.E.B. Goosen, H. Wijkstra, J.J.M.C.H. de la Rosette. Reproducibility of contrast-enhanced transrectal ultrasound of the prostate. Ultrasound in Med. & Biol 2001; (27): 595-602. 203. J.P.M. Sedelaar, P.L.M. Vijverberg, T.M. de Reijke, J.J.M.C.H. de la Rosette, P.J.M. Kil, J.G. Braeckman, A.J.M. Hendrikx. Transrectal Ultrasound in the Diagnosis of Prostate Cancer: State of the Art and Perspectives. Eur Urol 2001; (403): 275-284. 204. J.P.M. Sedelaar, J.G.H. van Roermund, G.L.J.H. van Leenders, C.A. Hulsbergen van de Kaa, H. Wijkstra, J.J.M.C.H. de la Rosette. Three-dimensional grayscale ultrasound: evaluation of prostate cancer compared with benign prostatic hyperplasia. Urology 2001; (57): 914-920. 205. D.L. Floratos, J.P.M. Sedelaar, B.B.M. Kortmann, R.G. Aarnink, H.Wijkstra, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Intra-Prostatic vasculature studies: can they predict the outcome of transurethral microwave thermotherapy for the management of bladder outflow obstruction? Prostate 2001; 46(3): 200-206. Curriculum Vitae 22 J. de la Rosette 206. J.J.M.C.H. de la Rosette, G. Alivizatos, M.P. Laguna. A critical evaluation of transurethral hot-water balloon thermoablation: true facts and fiction. Current Urology Reports 2001;(2 ):302-305. 207. J.J.M.C.H. de la Rosette. Editorial. Eur Urol 2001; 40(3): 264. 208. J.J.M.C.H. de la Rosette, G.Alivizatos, S. Madersbacher, M. Perachino, D. Thomas, F. Desgrandchamps, M. de Wildt. EAU Guidelines on Benign Prostatic Hyperplasia (BPH). Eur Urol 2001; (40): 256-263. 209. Y. Xue, G. Sonke, C. Schoots, J. Schalken, A. Verhofstad, J.J.M.C.H. de la Rosette, F. Smedts. Proliferative activity and branching morphogenesis in the human prostate: a closer look at pre- and postnatal prostate growth. The Prostate 2001; (49): 132-139. 210. J.J.M.C.H. de la Rosette. Introduction. Eur Urol 2001; 40(1). 211. A.L. Hoffmann, J.J.M.C.H. de la Rosette, H. Wijkstra. Intraprostatic temperature monitoring during transurethral microwave thermotherapy: status and future developments. J Endourol 2001; 14(8): 637-642. 212. D.L. Floratos, J.J.M.C.H. de la Rosette. The future role of microwave therapy in benign prostatic hyperplasia. Urol Integr Invest 2001; (6-3): 215-223. 2002: 213. M.P. Laguna, L.A. Kiemeney, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Baseline prostatic specific antigen does not predict the outcome of high energy transurethral microwave thermotherapy. J Urol 2002: 1727-1730. 214. G.S. Sonke, C.Robertson, A.L.M. Verbeek, W.P.J Witjes, J.J.M.C.H. de la Rosette, A method for estimating within-patient variability in maximum urinary flow rate adjusted for voided volume. Urology 2002; (59-3): 368-372. 215. J.J.M.C.H. de la Rosette, B.B.M. Kortman, C. Rossi, G.S. Sonke, D.L. Floratos, L.A.L.M. Kiemeney. Long-term risk of retreatment in patients using alpha-blockers for lower urinary tract symptoms. J Urol 2002; (167): 1734-1739. 216. J. Eckersley, J.P.M. Sedelaar, M.J. Blomley, H. Wijkstra, N.M. DeSouza, D.O. Cosgrove, J.J.M.C.H. de la Rosette. Quantitative microbubble enhanced transrectal ultrasound as tool for monitoring hormonal treatment of prostate cancer. Prostate june 2002 51(4): 256-267. 217. J.J.M.C.H. de la Rosette, D.K.E. van der Schoot, F.M.J. Debruyne. Recent developments in guidelines on benign prostatic hyperplasia. Current Opinion in Urology 2002; (12): 3-6. 218. J. de la Rosette F.Smedts, C. Schoots, H. Hoek, P. Laguna. Changing patterns of keratin expression characterize functional maturation in developing human bladder. J Urol 2002; 168(2): 709-717. 219. W.P.J. Witjes, J.J.M.C.H. de la Rosette, A. van den Berg-Segers, D. Colongo, G. Koch, A.R. Zlotta, A. Colau, M.J.A.M. de Wildt, H. Wijkstra. Computerised assessment of maximum urinary flow: an efficient, consistent and valid approach. Eur Urol 2002 41(2): 206-213. Curriculum Vitae 23 J. de la Rosette 220. B. Djavan, J.C. Nickel, J.J.M.C.H. de la Rosette, P.Abrams. The Urologist view of BPH progression: Results of an international servey. Eur. Urol 2002; 41(5): 490-496. 221. J.J.M.C.H. de la Rosette, C.C. Abbou, J. Rassweiler, M.P. Laguna, CC. Schulman. Laparoscopic radical prostatectomy: a European virus with global potentials. Arch. Esp. Urol. 2002; 55(6): 603-609. 222. P.C. Soeverein, R.M.C. Herings, A.J. Man in „t Veld, J.J.M.C.H. de la Rosette, R.D.T. Farmer, H.G.M. Leufkens. Study of the association between ischemic heart disease and use of alpha-blockers and finasteride indicated for the treatment of benign prostatic hyperplasia. Eur. Urol. 2002; 42: 254-261. 223. J. Veltman, T. Goossen, M.P. Laguna, H. Wijkstra, J.J.M.C.H. de la Rosette. New technical improvements for TRUS in diagnosis of prostate cancer. Eur Urol. Supplements 1; 2002; 1(6): 8-14. 224. J. Vanderkerken, J.J.M.C.H. de la Rosette, M.P. Laguna, F.M.J. Debruyne. How and when to take prostate biopsies. Eur. Urol. Supplements 1; 2002; 1(6): 15-20. 225. J.P.M. Sedelaar, G.J.L.H. van Leenders, T.E.B. Goossens, C.A. Hulsbergen-van der Kaa, N.P. van Adrichem, H. Wijkstra, J.J.M.C.H. de la Rosette. The value of contrast ultrasonography in the detection of significant prostate cancer: correlation with radical prostatectomy specimens. Prostate 2002; 53: 246-253. 2003: 226. P.C. Souverein, R.M.C. Herings, J.A. Erkens, J.J.M.C.H. de la Rosette, H.G.M. Leufkes, H.G.M. Leufkens. Drug treatment of benign prostatic hyperplasia and hospital admission for BPH-related surgery. Eur Urol. 2003; 43: 528-534. 227. A.L. Hoffmann, M.P. Laguna, J.J.M.C.H. de la Rosette, H. Wijkstra. Quantification of Prostate shrinkage after microwave thermotherapy: a comparison of calculated cell-kill versus 3D transrectal ultrasound planimetry. Eur. Urol. 2003; 181-187. 228. M. Emberton, G. Andriole, J. de la Rosette, B. Djavan, K. Hofner, V. Navarrete, J. Nordling, C. Roehrborn, C. Schulman, P. Teillac, A. Tubaro, C. Nickel. BPH: A progressive disease of the ageing male. Urology. 2003; 61: 267-273. 229. S. Gravas, M.P. Laguna, J.J.M.C.H. de la Rosette. Thermotherapy and thermoablation for BPH. Curr. Opnion Urol. 2003; 13: 45-49. 230. J.J.M.C.H. de la Rosette, M.P. Laguna, S.Gravas, M.J.A.M. de Wildt. Transurethral Microwave Thermotherapy: the 'gold standard' for minimal invasive therapies in patients with Benign prostatic Hyperplasia (BPH). Jour. Endourol 2003; 4: 245- 251 231. M.G. Harisinghani, J. Barentsz, P.F. Hahn, W.M. Deserno, S. Tabatabaei, C.H. van der Kaa., J.J.M.C.H. de la Rosette, R. Weissleder. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med. 2003;348(25):2491-9. 232. S.Gravas, M.P. Laguna, P.J. van Hest, J.J.M.C.H. de la Rosette. Efficacy and safety of intraprostatic temperature controlled microwave thermotherapy in patients with benign prostatic hyperplasia: Results of a porspective, open label, single center study with 1-year follow up. J. Endourol. 2003; 17: 425-430. Curriculum Vitae 24 J. de la Rosette 233. T.M. de Reijke, H.P.Beerlage, A.J. Hendrikx, J.J.M.C.H. de la Rosette, C.A. Mc.Killop. Prostate cancer: the right treatment for the right patient. Amsterdam 17 18 Januari 2001. Prostate Cancer Prostatic Dis. 2003; 6(2): 193-197. 234. B.W.Lagerveld, M.P. Laguna, J.J.M.C.H. de la Rosette. Long-term results after extrernal beam radiation therapy for T1-T2 localixes prostate cancer. Curr. Urol. Rep. 2003; 4:240-247. 235. D.L. Floratos, M.P. Laguna, L.A.L.M. Kiemeney, F.M.J. Debruyne, J.J. M.C.H. de la Rosette. Transurethral Resection versus Microwave Thermotherapy of the Prostate. A Cost-Consequences Analysis. BJU 2003; 92: 713-718. 236. C.A. Mochtar, L.A.L.M. Kiemeney, M.M. van Riemsdijk, G.S. Barnet, M.P. Laguna, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. PSA as an estimator of prostate volume in the management of patients with symptomatic BPH. Eur. Urol. 2003; 44: 65-700. 237. B.B.M. Kortmann, D.L. Floratos, L.A.L.M. Kiemeney, H. Wijkstra, J.J.M.C.H. de la Rosette. Urodynamic Effects of Alpha-Adrenoceptor Blockers: A Review of Clinical Trials. Urology 2003; 62:1-9. 238. T.E.B. Goossen, J.J.M.C.H. de la Rosette, C.A. Hulsbergen-van de Kaa, H. Wijkstra. The value of dynamic contrast enhanced power Doppler ultrasound imaging in the localization of prostate cancer. Eur Urol 2003. 43(2):124-131. 239. M.R. Engelbrecht, H.J. Huisman, R.J.R. Laheij, G.J. Jager, G.J.L.H. van Leenders, C.A. Hulsbergen-van de Kaa, J.J.M.C.H. de la Rosette, J.G. Blickman, J.O. Barentsz. Discrimination of prostate cancer from peripheral zone and central zone gland tissue using dynamic contrast-enhanced MR imaging. Radiology. 2003. 229(1):248-54. Epub 2003 Aug 27. 240. J.P.M. Sedelaar, J.J.M.C.H. de la Rosette, F.M.J. Debruyne. Progress in imaging of the prostate gland. Curr Urol Rep. 2003. 4(1):1-2. 2004: 241. M. Marberger., R. Harkaway, J.J.M.C.H. de la Rosette. Optimising the medical management of BPH. Eur. Urol. 2004; 45: 411-419. review 242. C. Huidobro, M. Bolmsjö, T. Larson, J.J.M.C.H. de la Rosette, L. Wagrell, S. Schelin, T. Gorecki, A. Mattiasson. Evaluation of Prostalund coretherm microwave theromotherapy with histo-pathology, MRI and temperature mapping. J.Urol. 2004; 171:672-678. 243. T. Horn, B.B. Kortmann, N.R. , F. Smedts, J. Nordling, L.A. Kiemeney, J.J.M.C.H. de la Rosette. Routine bladder biopties in men with bladder outlet obstruction? Urol. 2004; 63(3):451-456. 244. F.A. van Dorsten, M. van der Graaf, M.R. Engelbrecht, A. Verhofstad, A. van Leenders, M. Rijpkema, J.J.M.C.H. de la Rosette, J.O. Barentz, Heerschap. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer. J. Magn Reson Imaging. 2004; 20(2):279-287. Curriculum Vitae 25 J. de la Rosette 245. C. Roehrborn, J. de la Rosette, G. Andriole. The utility of serial PSA measurements for the diagnosis of prostate cancer is preserved in men treated with the dual 5αreductase inhibitor dutasteride. 246. M.C. Michel, J.J.M.C.H. de la Rosette. Efficacy and safety of tamsulosin in the treatment of urological diseases. Ashley Pub. Expert opinion Pharmacother. 2004; 5:1-10. 247. N. Naderi, C.A. Mochtar, J.J.M.C.H. de la Rosette. Real life practice in the management op BPH. Curr. Opin Urol 2004; 14: 41-44. 248. P. Bhowmick, J.E. Coad, S Bhowmick, J.L. Pryor, T. Larson, J.J.M.C.H. de la Rosette, J.C. Bischof. In vitro assessment of the efficacy of thermal therapy in human benign prostatic hyperplasia. Int. J. Hyperthermia. 2004; 20(4): 421-439. 249. F.A. van Dorsten, M. van der Graaf, M.R. Engelbrecht, G.J. van Leenders, A. Verhofstad, M. Rijpkema, J.J.M.C.H. de la Rosette, J.O. Barentsz, A. Heerschap. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer. J Magn Reson Imaging. 2004 Aug;20(2):279-87. 250. M.C. Michel, J.J.M.C.H. de la Rosette, M. Piro, M. Goepel. Does concomitant stress incontinence alter the efficacy of tolterodine in patients with overactive bladder? J Urol. 2004 Aug;172(2):601-4. 250. S. Madersbacher, G. Alivizatos, J. Nordling, C.R. Sanz, M. Emberton, J.J.M.C.H. de la Rosette. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol. 2004 Nov;46(5):547-54. 251. H.Wijkstra, M.H. Wink, J.J.M.C.H. de la Rosette. Contrast specific imaging in the detection and localization of prostate cancer.World J Urol. 2004; Oct 5. 252. M. Oelke, J.J.M.C.H. de la Rosette, M.C. Michel, U. Jonas. Medical therapy of urinary incontinence.Internist (Berl). 2004; Dec 18. 253. P. Boyle, C. Roehrborn, R. Harkaway, J. Logie, J.J.M.C.H. de la Rosette, M.Emberton. 5-Alpha reductase inhibition provides superior benefits to alpha blockade by preventing AUR and BPH-related surgery. Eur Urol. 2004 May;45(5):620-6; discussion 626-7. 2005: 254. A. Skolarikos, G. Alivizatos, J.J.M.C.H. de la Rosette. Percutaneous nephrolithotomy and its legacy. Eur. Urol. 2005; 47: 22-28 255. M.P. Laguna, L.C. Schreuders, J.J. Rassweiler, C.C. Abbou, R. van Velthoven, G. Janetschek, G. Breda, J.J.M.C.H. de la Rosette. Development of laparoscopic surgery ans training facilities in Europe: Results of a survey of the ESUT. Eur. Urol. 2005; 47: 346-351. 256. C.A. Mochtar, L.A..L.M. Kiemeney, M.P. Laguna, M.M. van Riemsdijk, G.S. Barnett, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Prognostic role of prostate-specific antigen and prostate volume for the risk of invasive therapy in patients with BPH initially managed with alpha1-blockers and watchful waiting. Urol. 2005; 65 (2):300305. Curriculum Vitae 26 J. de la Rosette 257. P.C. Souverein, M.M. van Riemsdijk, J.J.M.C.H. de la Rosette, P.C.E. Opdam, H.G.M. Leufkes. Treatment pf BPH and occurrence of prostatic surgery and aute urinary retention: A population-based cohort study in the Netherlands. Eur. Urol. 2005; 47:505-510. 258. M.M. Barendrecht, R.P. Koopmans, J.J.M.C.H. de la Rosette, M.C. Michel. Treatment of lower urinary tract symptoms suggestive of BPH : the cardiovascular system. BJU 2005; 95(4): 19-28. 259. B.W. Lagerveld, M.P. Laguna, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Holmium: YAG laser for treatment of strictures of vesicourethral anastomosis after radial prostatectomy. J. Endourol. 2005; 4 (19): 497-501 260. G. Kovacs, T. Loch, J. Hammer, R Potter, J.J.M.C.H. de la Rosette, H. Berterman. GEC-ESTRO-EAU recommendations on high dose rate brachytherapy for localized prostate cancer. J. Radiother Oncol. 2005; 74(2):137-148. 261. M. van Dijk, T. Skrekas, J.J.M.C.H. de la Rosette. The associotion between lower urinary tract symptoms ans sexual dysfunction: fact or fiction? Curr. Opin Urol 2005; 15:39-44. 262. Martin C. Michel, J.J.M.C.H. de la Rosette. Role of muscarinic receptor antagonists in urgency and nocturia. BJU 2005; 37-42 supp 1. 263. M. Oelke, J.J.M.C.H. de la Rosette, M.C. Michel, U. Jonas. Medical therapy of urinary incontinence. Internist 2005 Jan; 46(1): 75-82. 264. M.C. Michel, J.J.M.C.H. de la Rosette, M.Piro, T. Schneider. Comparison of symptom severity and treatment response in patients with incontinent and continent overactive bladder. European Urology 2005; 48: 110-115. 265. P.C. Kauer, M.P. Laguna, G. Alivizatos, A.Jocye, R.Muschter, R.Swartz, D.Tolley, J.J.M.C.H. de la Rosette. Present practice and treatment strategies in endourological stone management: results of a survey of the European society of uro-technology (ESUT). European Urology 2005; 48: 182-188. 266. H. Azzouz, J.J.M.C.H. de la Rosette. Radical prostatectomy in high-risk prostate cancer.Can J Urol. 2005 Jun; 12 Suppl 2: 33-7. 267. M.P. Laguna, M. Brenninkmeijer, J.A. Belon, R. Marrero, H. Wijkstra, J.J.M.C.H. de la Rosette, S. Isorna. Long-term functional and urodynamic results of 50 patients receiving a modified sigmoid neobladder created with a short distal segment. J Urol. 2005 Sep; 174(3): 963-7. 268. S. Gravas, M.P. Laguna, M. Ehrnebo, L. Wagrell, A. Mattiasson, J.J.M.C.H. de la Rosette. Seeking evidence that cell kill guided thermotherapy gives results not inferior to those of transurethral prostate resection: results of a pooled analysis of 3 studies of feedback transurethral microwave thermotherapy. J Urol. 2005 Sep; 174(3): 1002-6; discussion 1006. 269. M.P. Laguna M.P., B. Lagerveld, L.P. Witte, I. Kümmerlin, H. Wijkstra, J.J.M.C.H. de la Rosette. Laparoscopic assisted cryoablation of small renal masses. Actas Urol Esp. 2005 Oct; 29(9): 860-8. Curriculum Vitae 27 J. de la Rosette 270. M.P. Laguna, B. Lagerveld, J.J.M.C.H. de la Rosette. Tacticas y trucos endourologicos en el aparato uirnario inferior. Arch Esp Urol 2005; 58(8): 703-706. 271. M.P. Laguna, B. Lagerveld, J.J.M.C.H. de la Rosette. Tacticas y trucos endourologicos en el aparato urinario superior. Arch Esp Urol 2005; 58(8): 745-752. 272. M.P. Laguna, B. Lagerveld, J.J.M.C.H. de la Rosette. Tacticas y trucos endourologicos en laparoscopia. Arch Esp Urol 2005; 58(8): 789-800. 273. M.M. van Dijk , C.A. Mochtar, H. Wijkstra, M.P. Laguna, J.J.M.C.H. de la Rosette. Hourglass-shaped nitinol prostatic stent in treatment of patients with lower urinary tract symptoms due to bladder outlet obstruction. Urology 2005 Oct; 66(4): 845-9. 274. T. Skrekas, M.P. Laguna, J.J.M.C.H. de la Rosette. Laparoscopic radical prostatectomy: a European virus. Minimally Invasive Therapy 2005; 14:2: 98-103. 2006: 275. C.A. Mochtar, L.A. Kiemeney, M.M. van Riemsdijk, M.P. Laguna, F.M. Debruyne, J.J.M.C.H. de la Rosette. Post-void residual urine volume is not a good predictor of the need for invasive therapy among patients with benign prostatic hyperplasia. J Urol. 2006 Jan;175(1):213-6. 276. M.P. Laguna, A. Arce-Alcazar, C.A. Mochtar, R.V. van Velthoven, A. Peltier, J.J.M.C.H. de la Rosette. Construct validity of the chicken model in the simulation of laparoscopic radical prostatectomy suture. J Endourol. 2006 Jan;20(1):69-73. 277. M.M. van Dijk, C.A. Mochtar, H. Wijkstra, M.P. Laguna, J.J.M.C.H. de la Rosette. The bell-shaped nitinol prostatic stent in the treatment of lower urinary tract symptoms: experience in 108 patients. Eur Urol. 2006 Feb;49(2):353-9. 278. M.M. van Dijk, J.J.M.C.H de la Rosette, and M.C. Michel. Effects of alpha 1adrenoceptor antagonists on male sexual function. Drugs 2006; 66 (3):287-301. 279. M.P. Laguna, T.M. de Reijke, H. Wijkstra, J.J.M.C.H. de la Rosette. Training in laparoscopic urology. Current Opinion in Urology 2006; 16 (2):65-70. 280. C.A. Mochtar, W. Laan, K.P. Van Houwelingen, B. Franke, J.J.M.C.H. de la Rosette, J.A. Schalken, L.A.L.M. Kiemeney. Polymorphisms in the alpha(1A)adrenoceptor gene do not modify the short- and long-term efficacy of alpha(1)adrenoceptor antagonists in the treatment of benign prostatic hyperplasia. Bju International 2006; 97 (4):852-855. 281. P. Laguna, F. Smedts, J. Nordling, T. Horn, K. Bouchelouche, A. Hopman, J.J.M.C.H. de la Rosette. Keratin expression profiling of transitional epithelium in the painful bladder syndrome/interstitial cystitis. American Journal of Clinical Pathology 2006; 125 (1):105-110. 282. J.J.M.C.H. de la Rosette, G. Alivizatos. Lasers for the Treatment of Bladder Outlet Obstruction: Are They Challenging Conventional Treatment Modalities? Eur Urol. 2006; 50: 418-420. 283. M. Oelke, K. Höfner, U. Jonas, D. Ubbink, J.J.M.C.H. de la Rosette, H.Wijkstra. Ultrasound measurement of detrusor wall thickness in healthy adults.Neurourol Urodyn. 2006; 25(4): 308-17. Curriculum Vitae 28 J. de la Rosette 284. M.C. Michel, J.J.M.C.H. de la Rosette. Alpha-Blocker Treatment of Urolithiasis. Eur Urol. 2006; Mar 50: 213-214. 285. J.J.M.C.H. de la Rosette, T. Skrekas, J.W. Segura. Handling and Prevention of Complications in Stone Basketing.Eur Urol. 2006; 50: 991-999. 286. A. Skolarikos, G. Alivizatos, J.J.M.C.H. de la Rosette. Extracorporeal Shock Wave Lithotripsy 25 Years Later: Complications and their Prevention. Eur Urol. 2006; 50: 981-990. 287. C.A. Mochtar, L.A. Kiemeney, M.P. Laguna, F.M. Debruyne, J.J.M.C.H. de la Rosette. PSA velocity in conservatively managed BPH: Can it predict the need for BPH-related invasive therapy? Prostate. 2006 Sep 15; 66(13): 1407-12. 288. M.H. Wink, H. Wijkstra, J.J.M.C.H. de la Rosette, C.A. Grimbergen. Ultrasound imaging and contrast agents: a safe alternative to MRI? Minim Invasive Ther Allied Technol. 2006; 15(2):93-100. 289. S. Gravas, P.Laguna, M. Melekos, J.J.M.C.H. de la Rosette. Current status of minimally invasive treatment for benign prostatic obstruction. Acta Urológica 2006; 23 (1): 37-48. 290. K. Kijvikai, M.P. Laguna, J.J.M.C.H. de la Rosette. Control of the large renal vein in limited dissected space during laparoscopic nephrectomy: a simple and reliable method. International Journal of Urology 2006; 13: 851-853. 291. M.M.C. van den Heijkant, J.J.M.C.H. de la Rosette, T.M. de Reijke. Side effects of hormonal therapy in prostate cancer. Polish Journal of Urology 2006; 59(1): 5-8. 292. M.H. Wink, B.W. Lagerveld, M.P. Laguna, J.J.M.C.H. de la Rosette, H. Wijkstra. Cryotherapy for renal-cell cancer: diagnosis, treatment and contrast enhanced ultrasonography for follow-up. J Endourol. 2006; 20(7): 456-9. 293. H. Azzouz, J.J.M.C.H. de la Rosette. HIFU: local treatment of prostate cancer. EAU-EBU update series 4 2006: 62-70. 294. J. Rassweiler, D. Teber, J.J.M.C.H. de la Rosette, M.P. Laguna, V. Pansodoro, T. Frede. Laparoskopische beckenchirurgie. Wo stehen wir im jahr 2006? Urologe A 2006; Aug 10. 295. J.J.M.C.H. de la Rosette. Extracorporeal shock wave lithotripsy and the “end of stone age”. European Urology 2006; 50: 400-406. 296. J.J.M.C.H. de la Rosette. Optimising assessment and treatment decisions for men with BPH. European Urology 2006; 5: 710-715. 297. K. Kijvikai, M. van Dijk, M.P. Laguna Pes, P. Lertsithichai, H. Wijkstra, J.J.M.C.H. de la Rosette. Clinical utility of “blind placement” prostatic stent in patients with benign prostatic obstruction: a prospective study. Urology 2006; 68(5):1025-30. 298. T. Skrekas, C.A. Mochtar, B.W. Lagerveld, T.M. de Reijke, R.F. van Velthoven, J.J.M.C.H. de la Rosette, M.P. Laguna. Mentor-initiated approach in laparoscopic radical prostatectomy. J. Endourol 2006; 20(10): 831-5. Curriculum Vitae 29 J. de la Rosette 299. 2007: M.P. Laguna Pes, N. Wondergem, M.H. Wink, H. Wijkstra, J.J.M.C.H. de la Rosette. Avances en el diagnóstico ecográfico del cancer de prostate. Arch. Esp. Urol. 2006; 59(10): 965-976. 300. H.C. Arentsen, J.J.M.C.H. de la Rosette, T.M. de Reijke, S. Langbein. Fluorescence in situ hybridization: a multitarget approach in diagnosis and management of urothelial cancer. Expert rev Mol Diagn. 2007 Jan; 7(1): 11-9. 301. N. Wondergem, J.J.M.C.H. de la Rosette. HIFU and cryoablation – non or minimal touch techniques for the treatment of prostate cancer. Is there a role for contrast enhanced ultrasound? Minimally Invasive Therapy 2007; 16(1) : 22-30. 302. J. Rassweiler, M. Schulze, C. Stock, D. Teber, J.J.M.C.H. de la Rosette. Bipolar transurethral resection fo the prostate – technical modifications and early clinical experience. Minimally Invasive Therapy 2007; 16(1): 11-21. 303. M. Hatzinger, S. Langbein, J.J.M.C.H. de la Rosette, M. Sohn, P. Alken. Die Nephropexie im Wandel der Zeit Aspekte einer historischen Operationstechnik. Urologe A 2007; Jan 13. 304. A. Breda, SV Stepanian, J. Liao , JS. Lam, G. Guazzoni, M. Stifelman, K. Perry, A. Celia, G. Breda, P. Fornara, S. Jackman, J. Palo, M. Grasso, V. Pansadoro, V. Disanto, F. Porpiglia, C. Milani, C. Abbou, R. Gaston, G. Janetschek, N.A. Soomro, J.J.M.C.H. De la Rosette, M.P. Laguna, and P.G. Schulam. Positive margins in laparoscopic partial nephrectomy in 855 cases: a multi-institutional survey from USA and Europe. Journal of Urology 2007;178(1):47-50. 305. A. Skolarikos, G. Alivizatos, P. Laguna, J.J.M.C.H. de la Rosette. A review on follow-up strategies for renal cell carcinoma after nephrectomy. European Urology 2007 jun;51(6):1490-501. 306. M. Oelke, K. Höfner, U. Jonas, J.J.M.C.H. de la Rosette, D.T. Ubbink, H. Wijkstra. Diagnostic accuracy of non-invasive tests to evaluate bladder outlet obstruction in men: detrusor wall thickness, uroflowmetry, postvoid residual urine, and prostate volume. Eur. Urol. 2007;52:827-835. 307. J. Baard, Th.M. de Reijke, J.J.M.C.H. de la Rosette. The use of the Acucise technique for ureteroplevic junction obstruction: a trade-off between efficacy and invasiveness? Curr Urol Rep. 2007 Mar;8(2):134-9. 308. M. Wink, M.P Laguna, B.W. Lagerveld, J.J.M.C.H. de la Rosette, H. Wijkstra. Contrast-enhanced ultrasonography in the follow-up of cryoablation of renal tumours: a feasibility study. BJU int 2007 jun;99(6):1371-5. 309. S. Gravas, P Laguna, L.A. Kiemeney, J.J.M.C.H. de la Rosette. Durability of 30minute high-energy transurethral microwave therapy for treatment of beningn prostatic hyperplasia: a study of 213 patients with and without urinary retention. Urology 2007 may;69(5):854-8. 310. B.W. Lagerveld, R.D. ter Wee, J.J.M.C.H. de la Rosette, J.A. Spaan, H.Wijkstra. Vascular fluorescence casting and imaging cryomicrotomy for computerized threedimensional renal arterial reconstruction. BJU Int. 2007;100(2):387-91. Curriculum Vitae 30 J. de la Rosette 311. P. Tsakiris, J.J.M.C.H. de la Rosette. Imaging in genitourinary cancer from the urologists‟ perspective. Cancer Imaging 2007 May 28;7:84-92. 312. M.H. Wink, J.J.M.C.H. de la Rosette, M.P. Laguna, B.W. Lagerveld, H. Wijkstra. Ultrasonography of renal masses using contrast pulse sequence imaging: a pilot study. J Endourol. 2007;21(5):466-72. 313. A. Breda, S.V. Stepanian, J.S. Lam, J.C. Liao , I.S. Gill, J.R. Colombo, G. Guazzoni, K.T. Perry, A. Celia, G. Breda, P. Fornara, S.V. Jackman, A. Rosales, J. Palo, M. Grasso, V. Pansadoro, V. Disanto, F. Porpiglia, C. Milani, C. Abbou, R. Gaston, G. Janetschek, N.A. Soomro, J.J.M.C.H. De la Rosette, M.P. Laguna, and P.G. Schulam. Use of haemostatic agnets and glues during laparoscopic partial nephrectomy: a multi-institutional survey from the United States and Europe of 1347 cases. Eur. Urol. 2007;52(3): 798-803. 314. M.H. Wink, J.J.M.C.H. de la Rosette, C.A. Grimbergen, H. Wijkstra. Transrectal contrast enhanced ultrasound for diagnosis of prostate cancer. World J Urol. 2007; 25(4): 367-73. 315. T.M. de Reijke, J.J.M.C.H. de la Rosette, C.N. Sternberg. Treatment approacges in patients with hormone resistant prostate cancer. Polish Journal of Urology 2007;60(2):108-114. 316. S.K. Williams, J.J.M.C.H. de la Rosette, J. Landman, F.X. Keeley jr. Cryoablation of small renal tumors. EAU-EBU update series 2007;5:206-218. 317. M.M. Barendrecht, P. Abrams, H. Schumacher, J.J.M.C.H. de la Rosette, M.C. Michel. Do alpha1-adrenoceptor antagonists improve lower urinary tract symptoms by reducing bladder outlet resistance? Neurourol Urodyn 2007. 318. K. Kijvikai, G.E. Haleblian, G.M. Preminger, J.J.M.C.H. de la Rosette. Shock wave lithotripsy or ureteroscopy for the management of proximal ureteral calculi: an old discussion revisited. J Urol. 2007:178(4):1157-63. 319. I.P. Kümmerlin, J. Borrego, M.H. Wink, M.M. van Dijk, H. Wijkstra, J.J.M.C.H. de la Rosette, M.P. Laguna. Nephron-sparing surgery and percutaneous biopsies in renal-cell carcinoma: a global impression among endourologists. J Endourol. 2007;21(7):709-13. 320. C.A. Mochtar, P.C. Kauer, M.P. Laguna, J.J.M.C.H. de la Rosette. Urinary leakage after laparoscopic radical prostatectomy: a systematic review. J endourol. 2007;21(11):1371-80. 321. S. Gravas, M.D. Melekos, M.P. Laguna, J.J.M.C.H. de la Rosette. Evaluation of photoselective vaporization of the prostate. Aging Health 2007;3(6):723-730. 2008: 322. J. van der Wijk jr., J. van der Wijk sr., T. Horn, J.R. Nyengaard, H. Wijkstra, J. Nordling, F. Smedts, J.J.M.C.H. de la Rosette. Three-dimensional stereology as a tool for evaluating bladder outlet obstruction. Scand J Urol Nephrol. 2008;42:40-46. 323. P. Tsakiris, J.J.M.C.H. de la Rosette, M.C. Michel, M. Oelke. Pharmacologic treatment of male stress urinary incontinence: systematic review of the literature and levels of evidence. Eur. Urol. 2008;53(1):53-9. Curriculum Vitae 31 J. de la Rosette 324. G. Haleblian, K. Kijvikai, J.J.M.C.H. de la Rosette, G. Preminger. Ureteral stenting and urinary stone management: a systematic review. J Urol 2008;179(2):42430. 325. H. Wijkstra and J.J.M.C.H. de la Rosette. Editorial comment on: comparison of contrast-enhanced color doppler imaging (CDI), computerized tomography (CT), and magnetic resonance imaging (MRI) for the detection of crossing vessels in patients with ureteropelvic junction obstruction (UPJO). Eur. Urol. 2008;53(6):12601. 326. M. Emberton, M. Marberger, J.J.M.C.H. de la Rosette. Understanding patient and physican perceptions of benign prostatic hyperplasia in Europe: the prostate research on behaviour and education (PROBE) survey. Int J Clin Pract. 2008;62(1):18-26. 327. M. Trompetter, F. Smedts, J. van der Wijk, C. Schoots, H.J. de Jong, A. Hopman, J.J.M.C.H. de la Rosette. Keratin profiling in the developing human prostate. A different approach to understanding epithelial lineage. Anticancer Research 2008;28:237-244. 328. M.M. Barendrecht, P. Abrams, H. Schumacher, J.J.M.C.H. de la Rosette, M.C. Michel. Do alpha(1)-adrenoceptor antagonists imrove lower urinary tract symptoms by reducing bladder outlet resistance? Neurourol Urodyn. 2008;27(3):226-30. 329. I. Kümmerlin, F. ten Kate, F. Smedts, T. Horn, F. Algaba, I. Trias, J.J.M.C.H. de la Rosette, M.P. Laguna. Core biopsies of renal tumors: a study on diagnostic accuracy, interobserver, and intraobserver variability. Eur. Urol. 2008;53(6):1219-27. 330. L.P. Witte, C.R, Chapple, J.J.M.C.H. de la Rosette, M.C. Michel. Cholinergic innervation and muscarinic receptors in the human prostate. Eur Urol. 2008:54(2):326-34. 331. P. Tsakiris, S. Thüroff, J.J.M.C.H. de la Rosette, C. Chaussy. Transrectal highintensity focused ultrasound devices: a critical appraisal of the available evidence. J endourol. 2008;22(2):221-229. 332. P. Beemster, S. Phoa, H. Wijkstra, J.J.M.C.H. de la Rosette, M.P. Laguna. Followup of renal masses after cryosurgery using computed tomography; enhancement patterns and cryolesion size. BJU int. 2008;101(10):1237-42. 333. A. Skolarikos, J.J.M.C.H. de la Rosette. Prvention and treatment of complications following percutaneous nephrolithotomy. Curr Opin Urol. 2008:18(2):229-34. 334. M. Oelke, J. Baard, H. Wijkstra, J.J.M.C.H. de la Rosette, U. Jonas, K. Höfner. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostates hyperplasia. Eur Urol. 2008:54(2):41926. 335. J.J.M.C.H. de la Rosette. Facing the challenges of benign prostatic hyperplasia management. Curr Opin Urol. 2008;18(1):9-10. 336. J.J.M.C.H. de la Rosette, J. Rassweiler. Editorial: innovative approaches in endoscopic surgery. J Endourol. 2008 Apr;22(4):743-4. 337. S. Tabatabaei, O.M. Reich, J. de la Rosette, E.J. Collins, A. Bachmann, B.B. Choi, G.H. Muir, F.G. Sancha, H.H. Woo. International multicenter experience of the Curriculum Vitae 32 J. de la Rosette greenlight HPS120W laser in patients with benign prostatic obstruction. J of Urol. Suppl. S 2008; 179(4):627. 338. H.H. Woo, O.M. Reich, J. de la Rosette, E.J. Collins, A. Bachmann, B. Choi, G.H. Muir, F.G. Sancha, S. Tabatabaei. International multicenter experience of the greenlight HPS120W laser in patients with benign prostatic obstruction, in urinary retention, on anticoagulants and with large prostates. J of Urol. Suppl. S 2008;179(4):631. 339. J.J.M.C.H. de la Rosette, M.P. Laguna, J.J. Rassweiler, P. Conort. Training in Percutaneous Nephrolithotomy-A Critical Review. Eur Urol. 2008;54(5):994-1003. 340. M.C. Michel, U. Wetterauer, M. Vogel, J.J. de la Rosette. Cardiovascular safety and overall tolerability of solifenacin in routine clinical use: a 12-week, open-label, postmarketing surveillance study. Drug Saf. 2008;31(6):505-14. 341. S.F. Gomez, G. Muir, A. Bachmann, B. Choi, E. Collins, J. de la Rosette, O. Reich, S. Tabatabei, H. Woo. Green light HPS laser prostatectomy: recommendations on surgical technique. Eur. Urol. Supplements 2008;7(3):332. 342. B. Choi, S. Tabatabaein, A. Bachmann, E. Collins, J. de la Rosette, F. Gomez Sancha, G. Muir, O. Reich, H. Woo. GreenLight HPS 120-w laser for benign prostatic hyperplasia: Comparative complications and technical recommendations. Eur. Urol. Supplements. 2008;7(4):384-392. 343. J.J.M.C.H. de la Rosette, E. Collins, A. Bachmann, B. Choi, G. Muir, O. Reich, F. Gomez Sancha, S. Tabatabaei, H. Woo. Historical aspect of laser therapy for benign prostatic hyperplasia. Eur. Urol. Supplements. 2008;7(4):363-369. 344. G. Muir, F. Gomez Sancha, A. Bachmann, B. Choi, E. Collins, J. de la Rosette, O. Reich, S. Tabatabaei, H. Woo. Techniques and training with GreenLight HPS120-W laser therapy of the prostate: position paper. Eur. Urol. Supplements 2008;7(4):370377. 345. H. Woo, O. Reich, A. Bachmann, B. Choi, E. Collins, J. de la Rosette, F. Gomez Sancha, G. Muir, S. Tabatabaei. Outcome of GreenLight HPS 120-w laser therapy in specific patient populations: those in retention, on antocoagulants, and with large prostates (>=80 ml). Eur. Urol. Supplements 2008;7(4):378-383. 346. P. Sountoulides, J.J.M.C.H. de la Rosette. Update on photoselcetive vaporization of the prostate. Current Urology reports 2008;9:106-112. 347. H.C. Arentsen, S. Langbein, J.J.M.C.H. de la Rosette, R.C.M. Pelger, S.D. Bos, J.G. Fernandes, T.M. de Reijke. The nuclear matrix protein 22 (NMP22) bladderchek test for the detection of bladder cancer. Polish Journal of Urology 2008;61:24-27. 348. J.J.M.C.H. de la Rosette, S. Gravas, J.M. Fitzpatrick. Minimally Invasive treatment of male lower urinary tract symptoms. Urologic Clinics of North America 2008:35;505-518. 349. H. van Poppel, B. Tombal, J.J.M.C.H. de la Rosette, B.E. Persson, J.K. Jensen, T. Kold Olesen. Degarelix: a novel gonadotropin-releasing hormone (GnRH) receptor blocker-results from a 1-yr multicentre, randomized, phase 2 dosage-finding study in the treatment of prostate cancer. Eur. Urol. 2008;54(4):805-15. Curriculum Vitae 33 J. de la Rosette 350. I. Kümmerlin, F.J. ten Kate, H. Wijkstra, J.J.M.C.H. de la Rosette, M.P. Laguna Pes. Changes in the stage and surgical management of renal tumours during 19952005: an analysis of the Dutch national histopathology registry. BJU int. 2008;102(8):946-51. 351. M. Wink, F. Frauscher, D. Cosgrove, J.Y. Chapelon, L. Palwein, H. Mitterberger, C. Harvey, O. Rouvière, J.J.M.C.H. de la Rosette, H. Wijkstra. Contrast-enhanced ultrasound and prostate cancer; a multicentre European research coordination project. Eur Urol 2008;54(5):982-93. 352. P.W.T. Beemster, B.W. Lagerveld, L.P.W. Witte, J.J.M.C.H. de la Rosette, M. P. Laguna, H. Wijkstra. The Performance of 17-gauge cryoprobes in vitro. Technology in cancer research & treatment 2008;7(4):321-328. 353. J.Rioja, J.J.M.C.H. de la Rosette, H. Wijkstra, M.P. Laguna. Advances in diagnosis and follow-up in kidney cancer. Curr. Opin. Urol. 2008;18(5):447-54. 354. J.J.M.C.H. de la Rosette, P. Tsakiris, M.N. Ferrandino, A.M. Elsakka, J.Rioja, G.M. Preminger. Beyond prone position in percutaneous nephrolithotomy: a comprehensive review. Eur Urol 2008;54(6):1262-9. 355. J.J.M.C.H. de la Rosette. Editorial Comment: Holmium Laser Enucleation of the Prostate-Outcomes Independent of Prostate Size? J Urol 2008;180(6):2435. 356. J.J.M.C.H. de la Rosette. Editorial comment on: Endoscopic combined intrarenal surgery in Galdakao-modified supine Valdivia position : a new standard for percutaneous nephrolithotomy. Eur. Urol 2008;54(6):1400-1. 357. J.J.M.C.H. de la Rosette, J.J. Rassweiler. Bipolar TURP treatment for BPH refractory to medication: the past, present, and future reference standard. J. Endourol. 2008;22(9):2111-2. 358. J.J. de la Rosette, J.R. Zuazu, P. Tsakiris, A.M. Elsakka, J.J. Zudaire, M.P. Laguna, T.M. de Reijke. Prognostic factors and percutaneous nephrolithotomy morbidity: a multivariate analysis of a contemporary series using the clavien classification. J Urol 2008;180(6):2489-93. 359. A. Celia, G. Zeccolini, G. Guazzoni, V. Pansadoro, V. Disanto, F. Porpiglia, C. Milani, C. Abbou, R. Gaston, G. Janetschek, N.A. Soomroo, P. Fornara, A. Breda, P.G. Schulam, J.J. de la Rosette, M.P. Laguna, J. Palou, G. Breda. Laparoscopic nephron sparing surgery: a multi-institutional European survey of 592 cases. Arch Ital Urol Androl. 2008 Sep;80(3):85-91. 360. J. Rioja Zuazu, V. Totziaris, M.P. Laguna Pes, T.M. de Reijke, J.J. de la Rosette. Laser and bladder tumors. Arch Esp Urol 2008;61(9):994-1003. 2009: 361. J.J.M.C.H. de la Rosette. Editorial Comment on: Mid-term results demonstrate salvage High-Intensity Focused Ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer. Eur Urol. 2009;55(3):647-648. 362. I.P. Kümmerlin, F. Smedts, F.J. Ten Kate, T. Horn, F. Algaba, I. Trias, H. Wijkstra, J.J. de la Rosette, M.P. Laguna. Cytological Punctures in the Diagnosis of Renal Tumours: A Study on Accuracy and Reproducibility. Eur Urol. 2009;55(1):187-198. Curriculum Vitae 34 J. de la Rosette 363. I.P. Kümmerlin, F.J. Ten Kate, F. Smedts, T. Horn, F. Algaba, I. Trias, J.J. de la Rosette, M.P. Laguna. Diagnostic problems in the subtyping of renal tumors encountered by five pathologists. Pathol Res Pract. 2009;205(1):27-34. 364. C. Mamoulakis, M. Trompetter, J. de la Rosette. Bipolar transurethral resection of the prostate: the golden standard reclaims it leading position. Curr Opin Urol 2009;19(1):26-32. 365. J.J. de la Rosette. Tailoring treatment in benign prostatic hyperplasia management. Curr Opin Urol 2009;19(1):1-2. 366. L.P. Witte, W.M. Mulder, J.J. de la Rosette, M.C. Michel. Muscarinic receptor antagonists for overactive bladder treatment: does one fit all? Curr Opin Urol 2009;19(1):13-9. 367. M.C. Michel, R.F. Schäfers, J.J. de la Rosette. Drug interactions in urology. Urologe A. 2009;48(3):264-9. 368. M.P. Laguna, T.M. de Reijke, J.J. de la Rosette. How far will simulators be involved into training. Current Urology Reports 2009;10:97-105. 369. P. Tsakiris, P. Beemster, H. Wijkstra, J. de la Rosette, P. Laguna. In vivo factors influencing the freezing cycle during cryoablation of small renal masses. J Endourol. 2009;23(3):545-9. 370. T. Schneider, J.J. de la Rosette, M.C. Michel. Nocturia: a non-specific but important symptom of urological disease. Int J Urol. 2009;16(3):249-56. 371. P. Abrams, C. Chapple, S. Khoury, C. Roehrborn, J. de la Rosette. Evaluation and treatment of lower urinary tract symptoms in older men. J Urol. 2009;181(4):177987. 372. M. Oelke, C. Mamoulakis, D.T. Ubbink, J.J. de la Rosette, H. Wijkstra. Manual versus automatic bladder wall thickness measurements: a method comparison study. World J Urol. 2009 December; 27(6): 747–753. 373. E.C. Cauberg, D.M. de Bruin, D.J. Faber, T.G. van Leeuwen, J.J. de la Rosette, T.M. de Reijke. A new generation of optical diagnostics for bladder cancer: technology, diagnostic accuracy and future applications. Eur. Urol. 2009;56(2): 28796. 374. M.C. Michel, R.F. Schäfers, J.J. de la Rosette. Arzneimittelinteraktionen in der urologie. Urologe 2009;48:264-269. 375. E. Ramos-Barcelo, J. Rioja, P. Laguna Pes, J.J. de la Rosette, T. de Reijke. Is age a prognostic factor for treatment outocme in renal cell cancer-a comprehensive review. Crit Rev Oncol Hematol 2009;72(1):83-9. 376. V. Tzortzis, S. Gravas, M.M. Melekos, J.J. de la Rosette. Intraurethral lubricants: a critical literature review and recommendations. J endourol 2009;23(5):821-6. 377. V. Tzortzis, C. Mamoulakis, J. Rioja, S. Gravas, M.C. Michel, J.J. de la Rosette. Medical Expulsive Therapy for distal ureteral stones. Drugs 2009;69(6):677-692. Curriculum Vitae 35 J. de la Rosette 378. S. Gravas, C. Mamoulakis, J. Rioja, V. Tzortzis, T. de Reijke, H. Wijkstra, J.J. de la Rosette. Advances in ultrasound technology in oncologic urology. Urol Clin N Am 2009;36:133-145. 379. M.P. Laguna, P. Beemster, V.Kumar, S. Wyler, C. Anderson, F.X. Keeley, A. Bachmann, J. Rioja, C. Mamoulakis, M. Marberger, J.J. de la Rosette. Perioperative morbidity of laparoscopic cryoablation of small renal masses with ultrathin probes: a European multicentre experience. Eur. Urol. 2009;56(2):355-61. 380. P.W. Beemster, I. Trias, F.J.W. ten Kate, F. Algaba, H. Wijkstra, J.J. de la Rosette, M.P. Laguna Pes. The diagnostic yield of immediate postcryoablation biopsies of small renal masses. J of Endourol 2009;23(7):1203-7. 381. F. Wezel, C. Mamoulakis, J. Rioja, M.S. Michel, J. de la Rosette, P. Alken. Two contemporary series of percutaneous tract dilatation for percutaneous nephrolithotomy. J Endourol 2009;23(10):1655-61. 382. E.C. Cauberg, J.J. de la Rosette, T.M. de Reijke. How to improve the effectiveness of transurethral resection in nonmuscle invasive bladder cancer? Curr Opin Urol 2009;19(5):504-510. 383. M.P. Laguna, I. Kümmerlin, J. Rioja, J.J. de la Rosette. Biopsy of a renal mass: where are we now? Curr Opin Urol 2009;19(5):504-10. 384. P. Tsakiris, P. Beemster, H. Wijkstra, J. de la Rosette, P. Laguna. In vivo factors influencing the freezing cycle during cryoablation of small renal masses.J Endourol. 2009 Mar;23(3):545-9. 385. Meissner A., C. Mamoulakis, J.J. de la Rosette, M.P. Laguna Pes. Clinical update on testicular microlithiasis. Curr Opin Urol. 2009 Nov;19(6):615-8. 386. M.M. van Dijk, H. Wijkstra, F.M. Debruyne FM, J.J. de la Rosette, M.C. Michel. The role of nocturia in the quality of life of men with lower urinary tract symptoms. BJU Int. 2009;105:1141-1146. 387. H. Wijkstra, J.J.M.C.H. de la Rosette. Motion Corrected Cadence CPS Ultrasound for Quantifying Response to Vasoactive Drugs in a Rat Kidney Model Editorial Comment. Urology 2009;74(3): 681-682. 388. J.J. de la Rosette, M.H. Wink, C. Mamoulakis, N. Wondergem, F.J. ten Kate, K. Zwinderman, T.M. de Reijke, H. Wijkstra. Optimizing prostate cancer detection: 8 versus 12-core biopsy protocol. J Urol. 2009 Oct;182(4):1329-36. 389. C. Mamoulakis, D.T. Ubbink, J.J. de la Rosette. Bipolar versus Monopolar Transurethral Resection of the Prostate: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Eur Urol. 2009;56(5):798-809. 390. J. de la Rosette. A platform for global endourological research. J Endourol. 2009 Oct;23(10):1551-3. 391. J.J.M.C.H. de La Rosette, V. Mouraviev, T.J. Polascik. Focal Targeted Therapy Will Be a Future Treatment Modality for Early Stage Prostate Cancer. Eur Urol Suppl. 2009; 8(5): 424-432. Curriculum Vitae 36 J. de la Rosette 392. M.C. Martin, J.J.M.C.H. de la Rosette. Medical Treatment of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia. Eur Urol Suppl 2009; 8(6):496-503. 393. V. Tzortzis, S. Gravas, J.J.M.C.H. de La Rosette. Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia. Eur Urol Suppl 2009; 8(6): 513-522. 394. M.M. van Dijk, M.A. van Dijk, H.Wijkstra, M.P. Laguna, J.J.M.C.H. de la Rosette. The effect of temporary prostatic stent on sexual functioning. Central Eur J of Urol 2009;62(2):243-248. 395. P. Sountoulides, M.P. Laguna, J.J.M.C.H. de la Rosette. Complications follwing augmentation cystoplasty; prevention and management. Central Eur J of Urol 2009;62(2):216-221. 396. H. Sadri-Ardekani, S.C. Mizrak, S.K. van Daalen, C.M. Korver, H.L. RoepersGajadien, M. Koruji, S. Hovingh, T.M. de Reijke, J.J. de la Rosette, F. van der Veen, D.G. de Rooij, S. Repping, A.M. van Pelt. Propagation of Human Spermatogonial Stem Cells In Vitro. JAMA. 2009 Nov 18;302(19):2127-2134. 397. L.P.W. Witte, U.Peschers, M. Vogel, J.J.M.C.H. de la Rosette, M.C. Michel. Does the number of previous vaginal deliveries affect overactive bladder symptoms and their response to treatment. LUTS 2009;1:82-87. 398. J.J.M.C.H. de La Rosette. Editorial comment. J Endourol 2009;23(12):1949-50. 399. J.J.M.C.H. de La Rosette. Editorial comment Urology 2009;74(6)1357. 2010: 400. P. Sountoulides, M.M. van Dijk, H. Wijkstra, J.J. de la Rosette, M.C. Michel. Role of voiding and storage symptoms for the quality of life before and after treatment in men with voiding dysfunction. World J Urol. 2010 Feb;28(1):3-8. 401. E.C. Cauberg, M.A. Salomons, I.P. Kümmerlin, T.M. de Reijke, A.H. Zwinderman, J.J. de la Rosette, F.J. Kate, M.P. Laguna Pes. Trends in epidemiology and treatment of upper urinary tract tumours in the Netherlands 1995-2005: an analysis of PALGA, the Dutch national histopathology registry. BJU Int. 2010 Apr;105(7):922-7. 402. J. de la Rosette, S. Gravas. Global URS study: a prospective intenational observational study on indications and perioperative outcomes. J of Endourol 2010;24(1):1-3. 403. J. de la Rosette, S. Gravas. Guidelines for CROES publications. J of Endourol 2010;24(2):167-169. 404. R. Heuer, I.S. Gill, G. Guazzoni, Z. Kirkali, M. Marberger, J.P. Richie, J.J. de la Rosette. A Critical Analysis of the Actual Role of Minimally Invasive Surgery and Active Surveillance for Kidney Cancer. Eur Urol. 2010 Feb;57(2):223-32 405. S.C. Mizrak, J.V. Chikhovskaya, H. Sadri-Ardekani, S. van Daalen, C.M. Korver, S.E. Hovingh, H.L. Roepers-Gajadien, A. Raya, K. Fluiter, T.M. de Reijke, J.J. de la Rosette, A.C. Knegt, J.C. Belmonte, F. van der Veen, D.G. de Rooij, S. Repping, A.M. van Pelt. Embryonic stem cell-like cells derived from adult human testis. Hum Reprod. 2010;25(1):158-67. Curriculum Vitae 37 J. de la Rosette 406. G. Franco-Salinas, J.J. de la Rosette, M.C. Michel. Pharmacokinetics and pharmacodynamics of tamsulosin in its modified-release and oral controlled absorption system formulations. Clin Pharmacokinet. 2010 Mar 1;49(3):177-88. 407. J. de la Rosette, S. Gravas. Quality and transparency in CROES research projects. J of Endourol 2010;24(3):317.319. 408. J. Rioja Zuazu, M. Hruza, J.J. Rassweiler, J.J. de la Rosette. The Clavien classification system to optimize the documentation of PCNL morbidity. Archivio Italinano di Urologia e Andrologia 2010;82(1):20-2. 409. B.W. Lagerveld, P. van Horssen, M.P. Pes, J.P. van den Wijngaard, G.J. Streekstra, J.J. de la Rosette, H. Wijkstra, J.A. Spaan. Immediate Effect of Kidney Cryoablation on Renal Arterial Structure in a Porcine Model Studied by Imaging Cryomicrotome. J Urol. 2010 Mar;183(3):1221-1226. 410. J. de la Rosette, S. Gravas. Data transfer agreement form for CROES research projects. J of Endourol 2010;24(4):501-504. 411. E.C. Cauberg, S. Kloen, M. Visser, J.J. de la Rosette, M. Babjuk, V. Soukup, M. Pesl, J. Duskova, T.M. de Reijke TM. Narrow Band Imaging cystoscopy improves the detection of non-muscle-invasive bladder cancer. Urology. 2010;76(3):658-63. 412. S. Eggener, G. Salomon, P.T. Scardino, J. de la Rosette, T.J. Polascik , S. Brewster Focal therapy for prostate cancer: possibilities and limitations. Eur Urol. 2010 Jul;58(1):57-64. 413. J. de la Rosette, S. Gravas. A multi-center, randomized international study to compare the impact of narrow band imaging versus white light cystoscopy in the recurrence of bladder cancer. J Endourol. 2010 May;24(5):660-1. 414. P.W. Beemster, H. Wijkstra, J.J. de la Rosette, A.H. Zwinderman , M.P. Pes. Quality of life and perceived pain after laparoscopic-assisted renal cryoablation. J Endourol. 2010 May;24(5):713-9. 415. C. Mamoulakis, J.J. de la Rosette, D.T. Ubbink. Re: Burke et al.: systematic review and meta-analysis of transurethral resection of the prostate versus minimally invasive procedures for the treatment of benign prostatic obstruction (Urology 2010;75: 1015-1022). Urology. 2010 May;75(5):1235-6. 416. J. de la Rosette, I. Gill, T. Polascik. Focal therapy for prostate and renal cancer--are we ready for it? J Endourol. 2010 May;24(5):663. 417. J. de la Rosette, S. Gravas. Greenlight laser for benign prostatic hyperplasia study: a prospective international observational study on indications and perioperative outcomes. J of Endourol 2010;24(6):882-883. 418. J. de la Rosette, H. Ahmed, J. Barentsz, T.B. Johansen, M. Brausi, M. Emberton, F. Frauscher, D. Greene, M. Harisinghani, K. Haustermans, A. Heidenreich, G. Kovacs, M. Mason, R. Montironi, V. Mouraviev, T. de Reijke, S. Taneja, S. Thuroff , B. Tombal, J. Trachtenberg, H. Wijkstra, T. Polascik. Focal therapy in prostate cancer-report from a consensus panel. J Endourol. 2010 May;24(5):775-80. Curriculum Vitae 38 J. de la Rosette 419. A. Skolarikos, M.P. Laguna, G. Alivizatos, A.R. Kural, J.J. de la Rosette. The role for active monitoring in urinary stones: a systematic review. J Endourol. 2010 Jun;24(6):923-30. 420. J. de la Rosette, S. Gravas. Greenlight laser for benign prostatic hyperplasia study: a prospective international observational study on indications and perioperative outcomes. J Endourol. 2010 Jun;24(6):882-3. 421. J.J. de la Rosette. Editorial comment. Urology. 2010 Jun;75(6):1458. 422. M. Hruza, J.R. Zuazu, A.S. Goezen, J.J. de la Rosette, J.J. Rassweiler. Laparoscopic and open stone surgery. Arch Ital Urol Androl. 2010 Mar;82(1):64-71. 423. D.E. Zilberman, M.E. Lipkin, J.J. de la Rosette, M.N. Ferrandino, C. Mamoulakis, M.P. Laguna, G.M. Preminger. Tubeless percutaneous nephrolithotomy--the new standard of care? J Urol. 2010 Oct;184(4):1261-6. 424. R. Autorino, G.P. Haber, R.J. Stein, A. Rane, M. De Sio, M.A. White, B. Yang, J.J. de la Rosette, J.H. Kaouk, M.P. Laguna. Laparoscopic training in urology: critical analysis of current evidence. J Endourol. 2010 Sep;24(9):1377-90. 425. J. de la Rosette, S. Gravas. News from the publication office of CROES. J of Endourol 2010;24(8):1203-1205 426. I.P. Kümmerlin, F.J. ten Kate, H. Wijkstra, A. Zwinderman, J.J. de la Rosette, M.P. Laguna. A decade of surgically removed small renal masses in the Netherlands: characteristics and trends in type of surgery and pathologic reporting. J Endourol. 2010 Oct;24(10):1675-9. 427. J. de la Rosette, S. Gravas. Progress report on CROES studies. J of Endourol 2010;24(9):1373-1376. 428. J. de la Rosette, S. Gravas. News from CROES: time for acknowlegdment. J of Endourol 2010;24(8):1552-1555. 429. J. de la Rosette, S. Gravas. News from CROES: WCE 2010 and beyond. J Endourol 2010;24(11):1704-4. 430. E.C. Cauberg, D.M. de Bruin, D.J. Faber, T.M. de Reijke, M. Viseer, J. de la Rosette, T.G. van Leeuwen. Quantitave measurement of attenuation coefficients of bladder biopsies using optical coherence tomography for grading urothelial carcinoma of the bladder. J Biomed Opt. 2010:15(6):066013-6. 431. E.C.C. Cauberg, J.J. de la Rosette, T.M. de Reijke. Hematurie in de huisartspraktijk: een beknopt overzicht. Modern Medicine 2010;34(2):81-84. 432. J. de la Rosette, S. Gravas.Paul J. van Cangh: Food for thought. J of Endourol 2010;24(12):1895-1897. 2011: 433. K. Kijvikai, J.J. de la Rosette. Assessment of stone composition in the management of urinary stones. Nat Rev Urol. 2011;8(2):81-5. Curriculum Vitae 39 J. de la Rosette 434. E.C.C. Cauberg, C. Mamoulakis, J.J.M.C.H. de la Rosette, T.M. de Reijke. Narrow band imaging-assisted transurethral resection for non-muscle invasive bladder cancer significantly reduces residual tumour rate. World J Urol 2011; 29(4):503-9. 435. J. de la Rosette, R. Davis III, D. Frankel. T. Kold Olesen. Efficacy and safety of androgen deprivation therapy after switching from monthly leuprolide to monthly degarelix in patients with prostate cancer. Int J Clin Pract 2011;65(5):559-66. 436. M.C. Michel, M. Oelke, M. Vogel, J.J. de la Rosette. Which single-item measures of overactive bladder symptom treatment correlate best with patient satisfaction? Neurourology and urodynamics 2011;30(4):510-4. 437. S. van Rees Vellinga, J. de la Rosette. The CROES data management system: a glimpse behind the scenes. J Endourol 2011;25(1):1-5. 438. K. Barwari, D.M. de Bruin, E.C. Cauberg, D.J. Faber, T.G. van Leeuwen, H. Wijkstra, J. de la Rosette, M.P. Laguna. Advanced diagnostics in renal mass using optical coherence tomography: a preliminary report 2011;25(2):311-5. 439. J. de la Rosette, D. Assimos, M. Desai, J. Gutierrez, J. Lingeman, R. Scarpa, A. Tefekli. The Clinical Research Office of the Endourological Society percutaneous nephrolithotomy global study: indications, complications and outcomes in 5803 patients. J Endourol 2011;25(1):11-7. 440. P.W. Beemster, K. Barwari, C. Mamoulakis, H. Wijkstra, J.J. De La Rosette, M.P. Laguna. Laparoscopic renal cryoablation using ultrathin 17-gauge cryoprobes: midterm oncological and functional results. BJU Int. 2011;108(4):577-82. 441. J. Rioja, C. Mamoulakis, H. Sodha, S. Suwijn, P. Laguna, J. de la Rosette. A plea for centralized care for ureteroscopy: results from a comparative study under different conditions within the same center. J Endourol. 2011 Mar;25(3):425-9. 442. T. Lopes, K. Sangam, P. Alken, B.S. Barroilhet, C. Saussine, L. Shi, J. de la Rosette; Clinical Research Office of The Endourological Society Percutaneous Nephrolithotomy Study Group. The Clinical Research Office of the Endourological Society Percutaneous Nephrolithotomy Global Study: tract dilation comparisons in 5537 patients. J Endourol. 2011 May;25(5):755-62. 443. S. Gravas, A. Bachmann, O. Reich, C.G. Roehrborn, P.J. Gilling, J. de La Rosette. Critical review of lasers in benign prostatic hyperplasia (BPH). BJU Int. 2011 Apr;107(7):1030-43. 444. C. Mamoulakis, A. Skolarikos, M. Schulze, C.M. Scoffone, J.J. Rassweiler, G. Alivizatos, R.M. Scarpa, J.J. de la Rosette. Results from an international multicentre double-blind randomized controlled trial on the perioperative efficacy and safety of bipolar vs monopolar transurethral resection of the prostate. BJU Int. 2012 Jan;109(2):240-248. 445. A. Yamaguchi, A. Skolarikos, N.P. Buchholz, G.B. Chomón, M. Grasso, P. Saba, S. Nakada, J. de la Rosette; Clinical Research Office Of The Endourological Society. Percutaneous Nephrolithotomy Study Group. Operating times and bleeding complications in percutaneous nephrolithotomy: a comparison of tract dilation methods in 5,537 patients in the Clinical Research Office of the Endourological Society Percutaneous Nephrolithotomy Global Study. J Endourol. 2011 Jun;25(6):933-9. Curriculum Vitae 40 J. de la Rosette 446. K. Barwari, I.P. Kummerlin, F.J. Ten Kate, F. Algaba, I. Trias, H. Wijkstra, J.J. de la Rosette, P. Laguna. What is the added value of combined core biopsy and fine needle aspiration in the diagnostic process of renal tumours? World J Urol. 2011 May 28. [Epub ahead of print]. 447. M. Desai, A. De Lisa, B. Turna, J. Rioja, H. Walfridsson, A. D'Addessi, C. Wong, J.J. de la Rosette On Behalf Of The Croes Pcnl Study Group. The clinical research office of the endourological society percutaneous nephrolithotomy global study: staghorn versus nonstaghorn stones. J Endourol. 2011 Aug;25(8):1263-8. 448. B.W. Lagerveld, P. van Horssen, M.P. Laguna, J.P. van den Wijngaard, M. Siebes, H. Wijkstra, J.J. de la Rosette, J.A. Spaan. Gradient changes in porcine renal arterial vascular anatomy and blood flow after cryoablation. J Urol. 2011 Aug;186(2):681-6. 449. C.H. van der Vlies, D.C. Olthof, O.M. van Delden, K.J. Ponsen, J.J. de la Rosette, T.M. de Reijke, J.C. Goslings. Management of blunt renal injury in a level 1 trauma centre in view of the European guidelines. Injury. 2011 Jul 8. [Epub ahead of print] 450. P.J. Osther, H. Razvi, E. Liatsikos, T. Averch, A. Crisci, J.L. Garcia, A. Mandal A, J. de la Rosette; Croes PCNL Study Group. Percutaneous nephrolithotomy among patients with renal anomalies: patient characteristics and outcomes; a subgroup analysis of the clinical research office of the endourological society global percutaneous nephrolithotomy study. J Endourol. 2011 Oct;25(10):1627-32. 451. K. Barwari, P.W. Beemster, M.N. Hew, H. Wijkstra, J. de la Rosette, M.P. Laguna. Are there parameters that predict a nondiagnostic biopsy outcome taken during laparoscopic-assisted cryoablation of small renal tumors? J Endourol. 2011 Sep;25(9):1463-8. 452. E.C.C. Cauberg, J.J. de la Rosette, T.M. de Reijke. Emerging optical techniques in advanced cystoscopy for bladder cancer diagnosis: A review of the current literature. Indian J Urol. 2011 Apr;27(2):245-51. 453. M. Smeenge, M. Mischi, M.P. Laguna Pes, J.J. de la Rosette, H. Wijkstra. Novelcontrast-enhanced ultrasound imaging in prostate cancer. World J Urol. 2011 Oct;29(5):581-7. 454. E.C. Cauberg, C.Y. Nio, J.J. de la Rosette, M.P. Laguna, T.M. de Reijke. Computed tomography-urography for upper urinary tract imaging: is it required for all patients who present with hematuria? J Endourol. 2011 Nov;25(11):1733-40. 455. M.C. Rassweiler, C. Mamoulakis, H.G. Kenngott, J. Rassweiler, J. de la Rosette, M.P. Laguna. Classification and detection of errors in minimally invasive surgery. J Endourol. 2011 Nov;25(11):1713-21. 456. K. Barwari, D.M. De Bruin, D.J. Faber, T.G. Van Leeuwen, J.J. de La Rosette, M.P. Laguna. New optical diagnostic tools in renal cell cancer. Minerva Urol Nefrol. 2011 Sep;63(3):213-25. 457. J.G. Valdivia, R.M. Scarpa, M. Duvdevani, A.J. Gross, R.B. Nadler, K. Nutahara, J.J. de la Rosette; Croes PCNL Study Group. Supine versus prone position during percutaneous nephrolithotomy: a report from the clinical research office of the endourological society percutaneous nephrolithotomy global study. J Endourol. 2011 Oct;25(10):1619-25. Curriculum Vitae 41 J. de la Rosette 2012: 458. S. Gravas, V. Tzortzis, S.I. de la Riva, P. Laguna, J. de la Rosette. Focal therapy for prostate cancer: patient selection and evaluation. Expert Rev Anticancer Ther. 2012 Jan;12(1):77-86. 459. K. Barwari, J. de La Rosette, P. Laguna. The penetration of renal mass biopsy in daily practice: A survey among urologists. J Endourol. 2011 Dec 27. [Epub ahead of print] Curriculum Vitae 42 J. de la Rosette
© Copyright 2024